Method for manufacturing an intraocular hydrogel contact lens
The use of magnetized inserts with magnetic particles in the lens molding process addresses the challenge of accurate positioning and microbial contamination in intraocular hydrogel contact lenses, ensuring high-quality production.
Patent Information
- Application Number
- KR1020237028283
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2021-03-24
- Filing Date
- 2022-03-23
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2042-03-23
AI Technical Summary
Existing methods for manufacturing intraocular hydrogel contact lenses with embedded inserts face challenges in accurately positioning the inserts, leading to microbial loads due to holes formed by positioning guides, which are susceptible to contamination.
A method involving the use of magnetized inserts with magnetic particles, embedded in the lens mold using a magnet to ensure precise positioning during the molding process, eliminating the need for positioning guides and reducing microbial contamination.
The method allows for accurate and efficient embedding of inserts within the lens, reducing microbial loads and preventing delamination, resulting in a high-quality intraocular hydrogel contact lens.
Smart Images

Figure 112023091565432-PCT00037_ABST
Abstract
Description
Technology Field
[0001] The present invention generally relates to a method for manufacturing an embedded hydrogel contact lens. Furthermore, the present invention relates to an embedded hydrogel contact lens manufactured according to this method. Background Technology
[0002] Hydrogel contact lenses are widely used to correct various types of visual impairments due to their soft fit. Hydrogel contact lenses are made of a hydrated cross-linked polymer material in which the water content within the polymer matrix of the lens is about 20% by weight to about 75% by weight under equilibrium conditions. Generally, hydrogel contact lenses are manufactured according to a conventional full mold casting process. This conventional manufacturing process includes at least a lens molding step (i.e., a step of curing the polymerizable composition within the lens mold), a release step (i.e., a step of separating the lens from the mold), a lens extraction step using an extraction medium, a lens hydration step, and a packaging and sterilization step of the hydrated lens. Upon lens hydration, the hydrogel contact lens absorbs water and can typically swell significantly.
[0003] In recent years, regarding the use of various inserts incorporated into hydrogel contact lenses for various purposes such as corneal health, vision correction, and diagnosis, for example, U.S. Patent Nos. 4268132, 4401371, 5098546, 5156726, 6851805, 7104648, 7490936, 7883207, 7931832, 8154804, 8215770, 8348424, 8874182, 8922898, 9155614, 9176332, 9296158, 9618773, 9731437, and 9889615, It was proposed in No. 9977260, No. 10203521 and No. 10209534, and in U.S. patent applications Publication No. 2004 / 0141150, No. 2009 / 0091818, No. 2010 / 0076553, No. 2011 / 0157544 and No. 2012 / 0140167.
[0004] Generally, implants must be precisely positioned and secured at specific locations within the intraocular hydrogel contact lens. Fabricating intraocular hydrogel contact lenses by implanting one or more implants into specific locations is a considerably challenging task. A typical approach is to mold the intraocular hydrogel contact lens using a mold equipped with positioning guides (posts) on the molding surface. These positioning guides (posts) provide a means to accurately position the implant within the mold during the molding process. However, using a mold with such positioning guides (posts) results in the formation of small holes in the intraocular hydrogel contact lens due to the guides. These small holes in the intraocular hydrogel lens are susceptible to microbial loads.
[0005] Therefore, there is still a need to manufacture an intraocular hydrogel contact lens (preferably an intraocular silicone hydrogel contact lens) in which the insert is accurately positioned inside in a relatively efficient and consistent manner and can be easily implemented in a manufacturing environment.
[0006] In some embodiments, the present invention provides a method for manufacturing an intraocular hydrogel contact lens, the method of the present invention comprising: (1) a step of creating a magnetized insert having a diameter of about 13.0 mm or less and having a front surface and a rear surface opposite thereto, wherein the insert is made of a polymer material and includes magnetic particles; (2) a step of making a lens mold comprising a female half-mold having a first molding surface and a male half-mold having a second molding surface, wherein the female half-mold and the male half-mold are configured to accommodate each other so that a cavity is formed between the first molding surface and the second molding surface when the mold is closed; (3) a step of placing a magnetized insert and introducing a lens-forming composition, in any order, placing a magnetized insert in the lens mold and introducing a lens-forming composition into the lens mold, wherein the magnetized insert is immersed in the lens-forming composition within the lens mold and the magnetized insert is placed in the center of the lens mold and fixed in place using a magnet placed below the lens mold. (4) A lens-forming composition curing step in which a lens-forming composition is cured within a lens mold while a magnet is used to fix a magnetized insert in the center of the lens mold, thereby forming an unprocessed intraocular hydrogel contact lens, wherein a bulk hydrogel material produced from the lens-forming composition is included in the unprocessed intraocular hydrogel contact lens, and a magnetized insert is embedded in the bulk hydrogel material and placed in the center of the unprocessed intraocular hydrogel contact lens; (5) A lens mold separation step in which the lens mold produced in step (4) is separated into a female half-mold and a male half-mold, wherein the unprocessed intraocular hydrogel contact lens is attached to a lens-attaching half-mold, which is either the female half-mold or the male half-mold; (6) A step of removing the unprocessed ocular hydrogel contact lens from the lens-attachment half mold (preferably before the unprocessed ocular hydrogel contact lens comes into contact with water or any liquid);and (7) a post-forming process including a hydration process on an unprocessed ocular-implantable hydrogel contact lens, and one or more other processes selected from the group consisting of extraction, surface treatment, packaging, sterilization and combinations thereof.;
[0007] In another embodiment, the present invention provides an intraocular hydrogel contact lens comprising a front surface, a rear surface opposite thereto, a bulk hydrogel material, and a magnetized insert embedded in the bulk hydrogel material, wherein the magnetized insert is made of a polymer material and contains magnetic particles, the magnetized insert has a diameter of about 13.0 mm or less and has a front surface and a rear surface opposite thereto, the magnetized insert is located in the central part of the intraocular hydrogel contact lens, and the intraocular hydrogel contact lens is not easily delaminated, as evidenced by the absence of microscopically observable bubbles at the interface between the bulk material and the insert in the intraocular silicone hydrogel contact lens after autoclaving in a lens storage solution in a sealed package, and said lens storage solution is a buffered (physiological) saline solution with a pH of 7.1 ± 0.2.
[0008] The foregoing and other aspects of the present invention will become apparent from the following description regarding the preferred embodiments. Specific details for practicing the invention are merely illustrative of the invention and do not limit the scope of the invention as defined by the appended claims and their corresponding equivalents. As will be obvious to those skilled in the art, various variations and modifications of the invention are possible without departing from the spirit and scope of the novel concept of the invention. Brief explanation of the drawing
[0009] Figure 1 shows images of an unprocessed ocular SiHy contact lens obtained before opening the mold, where Figure 1a shows a magnetized insert (produced from an insert-forming composition containing 1 wt% magnetite) located in the center, and Figure 1b (control) shows a non-magnetized insert produced from an insert-forming composition containing no magnetite at all being off-center. Specific details for implementing the invention
[0010] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those skilled in the art to which this invention pertains. In general, the nomenclature and laboratory procedures used herein are widely known and commonly used in the art. These procedures utilize existing methods, such as those described in the prior art and various general references. Even if a term is referred to in the singular form, the inventors also consider the plural form of the term. The nomenclature used herein and the laboratory procedures described below are widely known and commonly used in the art.
[0011] The term "about" as used herein means that it includes a range of ±1 to 10% of the number cited by referring to it as "about".
[0012] "Contact lens" refers to a structure that may be placed on the surface of or within the wearer's eyeball. A contact lens may correct, improve, or alter the user's vision, but is not required to be used for such purposes. Contact lenses may be manufactured from any suitable material known in the art or to be developed in the future, and may be soft lenses, hard lenses, or implantable lenses.
[0013] "Hydrogel contact lens" refers to a contact lens containing a hydrogel bulk (core) material. The hydrogel bulk material may be a non-silicone hydrogel material, or preferably a silicone hydrogel material.
[0014] "Hydrogel" or "hydrogel material" refers to a crosslinked polymer material having a three-dimensional (3D) polymer network structure (i.e., a polymer substrate) and being water-insoluble, but having a water content of 10 weight% or more in a fully hydrated (or equilibrium) state.
[0015] Siloxane, often also referred to as silicon, refers to a molecule having one or more -Si-O-Si- moiety groups, and in the chemical formula, each Si atom has two organic groups as substituents.
[0016] "Silicone hydrogel" or "SiHy" refers to a silicon-containing hydrogel obtained by copolymerizing a polymerizable composition comprising one or more silicon-containing monomers, one or more silicon-containing macromonomers, or one or more crosslinkable silicon-containing prepolymers.
[0017] The terms "non-silicon hydrogel" or "non-silicon hydrogel material," used interchangeably herein, refer to a hydrogel that theoretically does not contain silicon.
[0018] The interchangeably used terms "horizontal half-mold" or "base curve half-mold" refer to a half-mold having a molding surface that is generally convex and defines the rear surface (back side) of a contact lens (or insert).
[0019] The interchangeably used terms "female half mold" or "front curve half mold" refer to a half mold having a molding surface that is generally concave and defines the front surface (front) of a contact lens (or insert).
[0020] As used herein, the terms "anterior surface," "front surface," "front curved surface," or "FC surface," used interchangeably with respect to contact lenses or implants, refer to the surface of the contact lens or implant facing away from the eye when worn. Typically, the anterior surface (front surface) is generally convex.
[0021] As used herein, the terms "rear surface," "rear surface," "base curve surface," or "BC surface," used interchangeably with respect to contact lenses or implants, refer to the surface of the contact lens or implant facing the eye when worn. Typically, the rear surface (rear surface) is generally concave.
[0022] "Integral hydrogel contact lens" refers to a hydrogel contact lens comprising one or more inserts completely or partially embedded within the bulk hydrogel material of the intraocular hydrogel contact lens.
[0023] In this invention, "implant" refers to any preformed article having a diameter of 13.0 mm or less, having a front surface and a rear surface opposite it, and a thickness smaller than any thickness of an intraocular hydrogel contact lens in the area where the implant is embedded. It is understood that the dimensions of the implant must be smaller than the dimensions of the intraocular hydrogel contact lens so as to be embedded in the bulk material of the intraocular hydrogel contact lens. The implant may be made of a polymer material that may be a non-hydrogel material or a hydrogel material. Preferred examples of implants include, but are not limited to, thin rigid implants providing a rigid central optical element for astigmatism occlusion, such as rigid gas permeable (RGP) contact lenses, multifocal lens implants, photochromic implants, cosmetic implants with a color pattern printed on the upper surface.
[0024] According to the present invention, the non-hydrogel material may be any material having a water absorption amount of less than 5 weight% in a fully hydrated state (preferably about 4 weight% or less, more preferably about 3 weight% or less, even more preferably about 2 weight% or less).
[0025] As used herein, the term "hydrophilic" refers to a substance or part thereof that can combine with water more easily than lipids.
[0026] The term "hydrophobic" used in relation to an insert or insert material means that the equilibrium water content (i.e., water content in a fully hydrated state) is less than 5% (preferably about 4% or less, more preferably about 3% or less, even more preferably about 2% or less).
[0027] The term "room temperature" refers to a temperature of about 22°C to about 26°C.
[0028] With respect to a compound or substance in a solvent, the term "soluble" means that the compound or substance can be dissolved in the solvent at room temperature (i.e., at a temperature of about 22°C to about 26°C) to provide a solution with a concentration of about 0.5% by weight or more.
[0029] With respect to a compound or substance in a solvent, the term “insoluble” means that the compound or substance can be dissolved in the solvent at room temperature (as defined above) to provide a solution with a concentration of less than about 0.01 weight%.
[0030] "Vinyl monomer" refers to a compound that has only one ethylene-based unsaturated group, is soluble in solvents, and can be polymerized by chemical rays or heat.
[0031] As used herein, the term "ethylene unsaturated group" is used in a broad sense and is intended to include any group containing one or more >C=C< groups. Examples of ethylene unsaturated groups include (meth)acryloyl ( and / or ), allyl, vinyl, styrenyl, or other C=C containing groups are included but not limited thereto.
[0032] "Acrylic monomer" refers to a vinyl monomer having a single (meth)acryloyl group. Examples of acrylic monomers include (meth)acryloxy [or (meth)acryloyloxy] monomers and (meth)acrylamido monomers.
[0033] "(Met)acryloxy monomer" or "(Met)acryloyloxy monomer" is a single or It refers to vinyl monomers having a group.
[0034] "(Met)acrylamido monomer" is a single or It refers to a vinyl monomer having a group, and R in the above formula 0 It is H or C1-C4 alkyl.
[0035] The term "aryl acrylic monomer" refers to an acrylic monomer having one or more aromatic rings.
[0036] "(Met)acryloxy monomer" or "(Met)acryloyloxy monomer" is a single or It refers to vinyl monomers having a group.
[0037] "(Met)acrylamido monomer" is a single or It refers to a vinyl monomer having a group, and R in the above formula 0 It is H or C1-C4 alkyl.
[0038] The term "(meth)acrylamide" refers to methacrylamide and / or acrylamide.
[0039] The term "(meth)acrylate" refers to methacrylates and / or acrylates.
[0040] "N-vinyl amide monomer" is a vinyl group directly bonded to the nitrogen atom of the amide group ( It refers to amide compounds having ).
[0041] "Ene monomer" refers to a vinyl monomer having only one en group.
[0042] The "en group" is not directly connected to a nitrogen atom, an oxygen atom, or a carbonyl group. or It refers to energy.
[0043] As used herein, “hydrophilic vinyl monomer,” “hydrophilic acrylic monomer,” “hydrophilic (meth)acryloxy monomer,” or “hydrophilic (meth)acrylamido monomer” each refers to a vinyl monomer, an acrylic monomer, a (meth)acryloxy monomer, or a (meth)acrylamido monomer that typically produces a homopolymer that is water-soluble or capable of absorbing 10 weight percent or more of water.
[0044] As used herein, “hydrophobic vinyl monomer,” “hydrophobic acrylic monomer,” “hydrophobic (meth)acryloxy monomer,” or “hydrophobic (meth)acrylamido monomer” each refers to a vinyl monomer, an acrylic monomer, a (meth)acryloxy monomer, or a (meth)acrylamido monomer that produces a homopolymer that is typically insoluble in water and capable of absorbing less than 10 weight percent of water.
[0045] As used herein, the term "vinyl crosslinking agent" refers to an organic compound having two or more ethylene-based unsaturated groups. The term "vinyl crosslinking agent" refers to a vinyl crosslinking agent having a molecular weight of 700 daltons or less.
[0046] "Acrylic crosslinking agent" refers to a vinyl crosslinking agent having two or more (meth)acryloyl groups.
[0047] The term "acrylic repeating unit" refers to a repeating unit of a polymeric material, and each repeating unit is derived from an acrylic monomer or an acrylic crosslinking agent in free-radical polymerization to form the polymeric material.
[0048] The term "terminal (meth)acryloyl group" refers to a (meth)acryloyl group located at one of the two ends of the main chain (or backbone) of an organic compound, as is known to those skilled in the art.
[0049] As used herein, in relation to the curing, crosslinking, or polymerization of polymerizable compositions, prepolymers, or materials, "by chemical radiation" (by chemical radiation) means that curing (e.g., crosslinking and / or polymerization) is performed by chemical radiation irradiation, such as UV / visible light irradiation, ionizing radiation (e.g., gamma rays or X-rays), microwave irradiation, etc. Thermal curing or chemical radiation curing methods are well known to those skilled in the art.
[0050] As used herein, the term "polymer" refers to a material formed by polymerizing or crosslinking one or more monomers, macromonomers, prepolymers, or combinations thereof.
[0051] "Macromonomer" or "prepolymer" refers to a compound or polymer containing an ethylene-based unsaturated group and having a number average molecular weight exceeding 700 daltons.
[0052] As used herein, the term “molecular weight” of a polymeric material (including monomeric or macromonomeric materials) refers to the number-average molecular weight unless specifically stated otherwise or test conditions otherwise indicated. Those skilled in the art may know of known methods, e.g., gel transmission chromatography (GPC) using one or more of a refractive index detector, a low-angle laser light scattering detector, a multi-angle laser light scattering detector, a differential viscometer detector, a UV detector, and an infrared (IR) detector; matrix-assisted desorption / ionization time-of-flight mass spectroscopy (MALDI-TOF MS); 1 I know how to measure the molecular weight of polymers using methods such as ¹H NMR (proton nuclear magnetic resonance) spectroscopy.
[0053] The terms "polysiloxane segment" or "polydiorganosiloxane segment," used interchangeably, refer to the chemical formula It is a polymer chain segment (i.e., a divalent radical) of the polymer chain. In the above formula, SN is an integer greater than or equal to 3, and R are independent of each other. S1 and R S2 Each is selected from the following group: C1-C 10 Alkyl; Phenyl; C1-C4-alkyl-substituted phenyl; C1-C4-alkoxy-substituted phenyl; Phenyl-C1-C6-alkyl; C1-C 10 Fluoroalkyl; C1-C 10 Fluoroether; aryl; aryl C1-C 18 Alkyl; -alk-(OC2H4) γ1 -OR o (In the formula, alk is a C1-C6 alkylene diradal, and R o is H or C1-C4 alkyl, and γ1 is an integer from 1 to 10); C2-C 40 As organic radicals, hydroxyl groups (-OH), carboxyl groups (-COOH), amino groups (-NR N1 R N1' ), -NR N1 - amino group, -CONR N1 - amide linkage of, -CONR N1 R N1' amide, -OCONH- urethane linkage, and C1-C4 alkoxy groups, or linear hydrophilic polymer chains (in the formula, R independent of each other). N1 and R N1' H or C1-C 15 C2-C having one or more functional groups selected from the group consisting of alkyls) 40 Organic radical; and photochromic organic radical having a photochromic group.
[0054] "Polysiloxane vinyl monomer" refers to a compound comprising one or more polysiloxane segments and a single ethylene-based unsaturated group.
[0055] The interchangeably used terms "polydiorganosiloxane vinyl crosslinker" or "polysiloxane vinyl crosslinker" refer to a compound comprising one or more polysiloxane segments and two or more ethylene-based unsaturated groups.
[0056] The interchangeably used terms "linear polydiorganosiloxane vinyl crosslinker" or "linear polysiloxane vinyl crosslinker" refer to a compound that contains one or more polysiloxane segments in a main chain and has one ethylene-based unsaturated group at each of the two ends of the main chain.
[0057] The interchangeably used terms "chain-extended polydiorganosiloxane vinyl crosslinker" or "chain-extended polysiloxane vinyl crosslinker" refer to a compound comprising two or more ethylene-based unsaturated groups and two or more polysiloxane segments, each pair of which is connected by one divalent radical.
[0058] The term "fluid" as used herein indicates that the substance can flow like a liquid.
[0059] As used herein, the term “transparent” in relation to a polymerizable composition refers to the polymerizable composition being a light-transmitting solution or liquid mixture (i.e., a light transmittance of 85% or more, preferably 90% or more, in the range of 400 nm to 700 nm).
[0060] The term "monovalent radical" refers to an organic radical obtained by removing a hydrogen atom from an organic compound and forming a bond with one other group within the organic compound. Examples of such monovalent radicals include, but are not limited to, alkyl (obtained by removing a hydrogen atom from an alkane), alkoxy (or alkoxyl) (obtained by removing one hydrogen atom from the hydroxyl group of an alkyl alcohol), thiyl (obtained by removing a hydrogen atom from the thiol group of an alkylthiol), cycloalkyl (obtained by removing a hydrogen atom from a cycloalkane), cycloheteroalkyl (obtained by removing a hydrogen atom from a cycloheteroalkane), aryl (obtained by removing a hydrogen atom from the aromatic ring of an aromatic hydrocarbon), heteroaryl (obtained by removing a hydrogen atom from all ring atoms), and amino (obtained by removing a hydrogen atom from an amine).
[0061] The term "divalent radical" refers to an organic radical obtained by removing two hydrogen atoms from an organic compound and forming two bonds with two other groups within the organic compound. For example, the alkylene divalent radical (i.e., alkylenyl) is obtained by removing two hydrogen atoms from an alkane, and the cycloalkylene divalent radical (i.e., cycloalkylenyl) is obtained by removing two hydrogen atoms from a cyclic ring.
[0062] In this document, the term “substituted” used in relation to alkyl or alkylenyl means that a hydrogen atom in alkyl or alkylenyl is replaced by one or more substituents selected from the group consisting of hydroxyl (-OH), carboxyl (-COOH), -NH2, sulfhydryl (-SH), C1-C4 alkyl, C1-C4 alkoxy, C1-C4 alkylthio(alkylsulfide), C1-C4 acylamino, C1-C4 alkylamino, di-C1-C4 alkylamino, and combinations thereof.
[0063] A free radical initiator may be either a photoinitiator or a thermal initiator. A "photoinitiator" refers to a chemical substance that uses light to initiate a free radical crosslinking / polymerization reaction. A "thermal initiator" refers to a chemical substance that uses thermal energy to initiate a free radical crosslinking / polymerization reaction.
[0064] The "oxygen permeability" (Dk i ) is the ratio of oxygen passing through the substance and can be measured at approximately 34°C to 35°C according to the procedure described in Example 1. Oxygen permeability is generally expressed in units of "barrer," where "barrer" is [(cm 3 Oxygen)(mm) / (cm 2 )(sec)(mm Hg)] x 10 -10 It is defined as.
[0065] The "oxygen transfer rate" (Dk / t) of an insert or material is the ratio of oxygen passing through the insert or material over the area to be measured, based on the average thickness (t) [unit: mm]. The oxygen transfer rate is generally expressed in units of barr / mm, where "barr / mm" is [(cm 3 Oxygen) / (cm² 2 )(sec)(mm Hg)] x 10 -9 It is defined as.
[0066] The terms "modulus" or "elastic modulus" used in relation to contact lenses or materials refer to the tensile modulus or Young's modulus, which is a measure of the hardness of the contact lens or material. The modulus can be measured according to the procedure described in Example 1.
[0067] "Unprocessed state" refers to a state in which an insert obtained by mold casting a polymerizable composition within a mold has not undergone a post-molding process after extraction and / or hydration (i.e., has not come into contact with water, any organic solvent, or any liquid at all after molding).
[0068] Generally, the present invention relates to a method for manufacturing an intraocular hydrogel contact lens having an insert containing magnetic particles that is completely or partially embedded in the bulk hydrogel material of the intraocular hydrogel contact lens. The present invention is based on the discovery that an insert containing magnetic particles on top and inside (i.e., a magnetized insert) can be placed at a central or any target location within a lens mold for contact lens molding using a magnet placed below the lens mold. By using the magnetized insert in combination with a magnet, the inserts can be accurately positioned during the molding step in the method according to the present invention. Using a magnetized insert can simplify the production process of the intraocular hydrogel contact lens and can also easily be implemented in an automated production manner. In addition, the method of the present invention can eliminate the accumulation of protein and / or microbial loads in these holes in an intraocular hydrogel contact lens by avoiding the use of positioning guides (posts) and eliminating the various holes that occur in these positioning guides (posts).
[0069] In some embodiments, the present invention provides a method for manufacturing an intraocular hydrogel contact lens, the method of the present invention comprising: (1) a step of creating a magnetized insert having a diameter of about 13.0 mm or less and having a front surface and a rear surface opposite thereto, wherein the insert is made of a polymer material and includes magnetic particles; (2) a step of making a lens mold comprising a female half-mold having a first molding surface and a male half-mold having a second molding surface, wherein the female half-mold and the male half-mold are configured to accommodate each other so that a cavity is formed between the first molding surface and the second molding surface when the mold is closed; (3) a step of placing a magnetized insert and introducing a lens-forming composition, in any order, placing a magnetized insert in the lens mold and introducing a lens-forming composition into the lens mold, wherein the magnetized insert is immersed in the lens-forming composition within the lens mold and the magnetized insert is placed in the center of the lens mold and fixed in place using a magnet placed below the lens mold. (4) A lens-forming composition curing step in which a lens-forming composition is cured within a lens mold while a magnet is used to fix a magnetized insert in the center of the lens mold, thereby forming an unprocessed intraocular hydrogel contact lens, wherein a bulk hydrogel material produced from the lens-forming composition is included in the unprocessed intraocular hydrogel contact lens, and a magnetized insert is embedded in the bulk hydrogel material and placed in the center of the unprocessed intraocular hydrogel contact lens; (5) A lens mold separation step in which the lens mold produced in step (4) is separated into a female half-mold and a male half-mold, wherein the unprocessed intraocular hydrogel contact lens is attached to a lens-attaching half-mold, which is either the female half-mold or the male half-mold; (6) A step of removing the unprocessed ocular hydrogel contact lens from the lens-attachment half mold (preferably before the unprocessed ocular hydrogel contact lens comes into contact with water or any liquid);and (7) a post-forming process including a hydration process on an unprocessed ocular-implantable hydrogel contact lens, and one or more other processes selected from the group consisting of extraction, surface treatment, packaging, sterilization and combinations thereof.;
[0070] In another embodiment, the present invention provides an intraocular hydrogel contact lens comprising a front surface, a rear surface opposite thereto, a bulk hydrogel material, and a magnetized insert embedded in the bulk hydrogel material, wherein the magnetized insert is made of a polymer material and contains magnetic particles, the magnetized insert has a diameter of about 13.0 mm or less and has a front surface and a rear surface opposite thereto, the magnetized insert is located in the central part of the intraocular hydrogel contact lens, and the intraocular hydrogel contact lens is not easily delaminated, as evidenced by the absence of microscopically observable bubbles at the interface between the bulk material and the insert in the intraocular silicone hydrogel contact lens after autoclaving in a lens storage solution in a sealed package, and said lens storage solution is a buffered saline solution with a pH of 7.1 ± 0.2.
[0071] Half molds for manufacturing contact lenses (or inserts) that are well known to those skilled in the art are utilized, for example, in mold casting. Generally, a molding assembly consists of at least two half molds, namely one male half mold and one female half mold. The male half mold has a first molding (or optical) surface that is in direct contact with a polymerizable composition for mold casting of the contact lens (or insert) and defines the rear surface (rear side) of the molded contact lens (or molded insert); and the female half mold has a second molding (or optical) surface that is in direct contact with the polymerizable composition and defines the front surface (front side) of the molded contact lens (or molded insert). As the male half mold and the female half mold are configured to receive each other, a lens- or insert-molding cavity is formed between the first molding surface and the second molding surface.
[0072] Methods for manufacturing half molds for casting contact lenses or implants are generally well known to those skilled in the art. The process of the present invention is not limited to any specific method of forming half molds. In fact, any method of forming half molds may be used in the present invention. These half molds may be formed by various techniques such as injection molding or lathing. Examples of processes suitable for forming half molds are disclosed in U.S. Patents No. 4444711; 4460534; 5843346; and 5894002.
[0073] Almost all materials known in the art for the production of half molds can be used to manufacture half molds for contact lenses or implants. For example, polyethylene, polypropylene, polystyrene, PMMA, Topas ® Polymer materials such as COC grade 8007-S10 (a transparent amorphous copolymer of ethylene and norbornene, available from Ticona GmbH in Frankfurt, Germany and Summit in New Jersey, USA) can be used.
[0074] In this document, "magnetized insert" refers to an insert containing magnetic particles inside and / or on top.
[0075] All types of magnetic particles can be used in the present invention. Nano- and micro-sized magnetic particles are well known in the art and have been used in magnetic particle imaging (MPI), separation and inspection, as well as in biomedical, energy, electronics, and environmental fields (cf. Colloidal Metal Oxide Nanoparticles: Synthesis, Characterization and Applications (Metal Oxides), Ed. by S Thomas, AT Sunny and P. Velayudhan, Elsevier, 1st edition (September 15, 2019)). Magnetic particles having a very wide range of particle sizes can be obtained from commercial suppliers, such as Chemcell GmbH (Berlin, Germany) and Creative Diagnostics (Shirley, New York, USA), or manufactured by any method known to those skilled in the art (e.g., U.S. Patents No. 3926659, 6302952, 9846263 and 10253191; and U.S. Patent Application Publications No. 2004 / 0038355, 2007 / 0032573 and 2009 / 0255442).
[0076] In a preferred embodiment, the magnetized insert is made of a polymer material and includes magnetic particles distributed in the polymer material. This type of magnetized insert can be obtained by mold casting a composition for forming an insert (i.e., a polymerizable composition for forming an insert) containing magnetic particles.
[0077] In another preferred embodiment, the magnetized insert is made of a polymer material and has a magnetic coating thereon. This type of magnetized insert can be obtained by applying a magnetic coating composition to either the front or back surface of a preformed insert. The magnetic coating composition comprises magnetic particles and can be prepared by adding magnetic particles to any coating composition known to those skilled in the art.
[0078] In another preferred embodiment, the magnetization insert is made of a polymer material and includes a magnetic color image thereon.
[0079] The “magnetic color image” comprises any cosmetic pattern, such as an annular ring (e.g., illustrated in FIGS. 1–6 of U.S. Patent No. 8770747, FIGS. 1–7 of U.S. Patent No. 9039173, and FIGS. 1–8 of U.S. Patent No. 10156736), a simulated iris pattern (e.g., illustrated in U.S. Patents No. 3536386; No. 3679504; No. 3712718; No. 4460523; No. 4582402; No. 4634449; No. 4719657; No. 4744647; No. 5120121; No. 5414477; No. 5793466, No. 7278736), and a preformed insert comprising magnetic particles on either the front or back surface. It refers to the Wild Eye™ pattern printed using ink.
[0080] Any type of ink containing magnetic particles may be used in the present invention. Generally, the ink consists of pigment particles, one or more binder polymers, and a solvent. The ink optionally includes a crosslinking agent, a wetting agent, a surfactant, a monomer, a polymerization initiator, an antimicrobial agent, an antioxidant, an anti-kogation agent, and other additives known in the art. Those skilled in the art are well aware of the methods for manufacturing inks used to print color images on preformed contact lenses. Numerous types of inks used to print color images on contact lenses are known in the art and are disclosed in various patents. Ink containing magnetic particles may be prepared by adding magnetic particles to any known ink, or by mixing all essential components containing magnetic particles in a solvent.
[0081] A person skilled in the art knows how to obtain a preformed insert having a magnetic color image through any known method.
[0082] One of the well-known methods is to directly print ink containing magnetic particles onto at least one of the front or back surfaces of a preformed insert according to pad transfer printing and / or inkjet printing techniques.
[0083] Pad transfer printing is well known in the art (e.g., U.S. Patent No. 3,536,386 granted to Spivack, U.S. Patents No. 4,582,402 and 4,704,017 granted to Knapp, and U.S. Patent No. 5,034,166 granted to Rawlings et al., the whole incorporated herein by reference). A typical example of such a printing method is as follows: An image is etched into a metal to form a printing plate (cliche). The printing plate is placed in a printing press. Ink is applied to the printing plate placed inside the printing press by a closed ink cup that slides over the entire image or by an open inkwell doctoring system. Then, a silicone pad picks up the inked image from the printing plate and transfers the image to a contact lens. The silicone pad is made of a material containing silicone, which may have varying elasticity. Due to the properties of the silicone material, the ink may be temporarily attached to the pad and may be completely separated from the pad when in contact with a pre-formed insert or a mold for forming the insert. Examples of suitable pad-transfer printing structures include, but are not limited to, Tampo-type printing structures (Tampo vario 90 / 130), rubber stamps, thimbles, doctor blades, direct prints, or transfer prints known in the art.
[0084] Any known suitable silicone pad may be used in the present invention. Silicone pads are commercially available. However, different pads may provide different print qualities. Those skilled in the art will know which pad to select for a given ink.
[0085] The printing plate may be made of ceramic or metal (e.g., steel). If the printing plate is made of steel, it may be desirable to add a buffer (e.g., phosphate) to neutralize the pH of the water-based ink (e.g., to adjust the pH to 6.8 to 7.8). An image may be etched onto the printing plate by any method known to those skilled in the art, such as chemical etching or laser ablation. Additionally, after use, it is desirable to clean the printing plate using standard cleaning techniques known to those skilled in the art, such as immersion in a solvent, ultrasonic treatment, or mechanical polishing.
[0086] It should be understood that printing can be done on the front and / or back of the pre-molded insert.
[0087] Print on a preformed insert using an inkjet printing process similar to that described in U.S. Patent Applications Publication Nos. 2001 / 0050753, 2001 / 0085934, 2003 / 0119943, and 2003 / 0184710.
[0088] Alternatively, a preformed insert with a magnetic color image printed on its upper surface can be produced through a process of printing directly onto the mold surface, similar to that described in U.S. Patent No. 5034166. First, ink can be applied to the molding surfaces of one or both of the half-molds using pad transfer printing (or pad printing) or inkjet printing techniques to form a magnetic colored coat (having a magnetic color image). The magnetic colored coat can be applied to the molding surface defining the front or back of the insert to be formed, or to both molding surfaces defining the front and back of the insert to be formed, respectively.
[0089] After printing ink on the molding surface of the mold, the printed ink can be cured by heat or chemical irradiation. In order to minimize to some extent the loss of pattern definition of the magnetic color image that occurs while subsequently filling with a composition for forming an insert, it is preferable to cure the printed ink by chemical irradiation. Subsequently, by introducing a composition for forming an insert into the mold on which the magnetic color image is printed on the molding surface and then curing it, a magnetic insert having a magnetic color image on either the front or back side is formed.
[0090] All polymerizable compositions, such as those known to be suitable for manufacturing hard contact lenses, soft contact lenses, non-silicone hydrogel contact lenses, silicone hydrogel contact lenses, and artificial lenses, can be used as lens-forming compositions.
[0091] In a preferred embodiment, the magnetized insert is made of a rigid plastic (preferably cross-linked polymethyl methacrylate).
[0092] In another preferred embodiment, the magnetized insert is made of a cross-linked silicone polymer (or silicone rubber or elastomer known to those skilled in the art). The cross-linked silicone material has a stereopolymer network structure (i.e., a polymer substrate), is water-insoluble, and has an equilibrium moisture content (i.e., water content in a fully hydrated state) of about 5 weight% or less, preferably about 3 weight% or less, more preferably about 2 weight% or less.
[0093] In another preferred embodiment, the magnetized insert is made of a non-silicon hydrogel material (any one of which is described below).
[0094] In another preferred embodiment, the magnetized insert is made of a silicone hydrogel material (any one of which is described below).
[0095] In another preferred embodiment, the magnetization insert is made of a hard gas-permeable material (e.g., a material produced from fluorosilicon acrylate).
[0096] In another preferred embodiment, the magnetized insert comprises a repeating unit of one or more polymerizable photochromic compounds (i.e., one or more photochromic vinyl monomers), a repeating unit of one or more UV-absorbing vinyl monomers, a repeating unit of one or more UV / HEVL-absorbing vinyl monomers, a repeating unit of fluorescent vinyl monomers, or a combination thereof.
[0097] In another preferred embodiment, the magnetized insert comprises one or more photochromic dyes or pigments, one or more color filtering materials for colorblind correction, diffractive materials, high refractive index materials, or a combination thereof.
[0098] In another preferred embodiment, the magnetized insert is made of a hydrophobic crosslinked acrylic material having an equilibrium moisture content of less than 5 weight%, containing at least about 55 mol% (preferably at least about 60 mol%, more preferably at least about 65 mol%, even more preferably at least about 70 mol%) of repeating units of one or more acrylic monomers and / or one or more acrylic crosslinking agents and at least about 6 mol% (preferably at least about 8 mol%, more preferably at least about 10 mol%, even more preferably at least about 12 mol%) of repeating units of one or more vinyl crosslinking agents.
[0099] Any hydrophobic acrylic monomer may be used to form the hydrophobic material of the present invention. Examples of hydrophobic acrylic monomers include silicon-containing acrylic monomers (any one described below), non-silicon hydrophobic acrylic monomers (any one described below), fluorine-containing acrylic monomers (any one described below), aryl acrylic monomers described below, and combinations thereof.
[0100] According to a preferred embodiment of the present invention, a hydrophobic crosslinked acrylic material comprises an aryl vinyl monomer of the following formula I or II:
[0101] [Chemical Formula I]
[0102]
[0103] [Chemical Formula II]
[0104]
[0105] In the formula, A1 is H or CH3 (preferably H); and B1 is (CH2) m1 or [O(CH2)2] Z1 (m1 is 2 to 6, and z1 is 1 to 10); Y1 is directly bonded, O, S, or NR'(R' is H, CH3, C n' H 2n'+1 (n' is 1 to 10, iso-OC3H7, C6H5 or CH2C6H5) and; R a , R b , R c , R d , R e , R f , R g , R h and R i are independently H, C1-C 12 alkyl or C1-C 12 It is an alkoxy (preferably all H); where m1+w1≤8, w1 is 0 to 6; w2 is an integer from 1 to 3; and D1 is H, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C6H5 or CH2C6H5.
[0106] Examples of aryl acrylic monomers of Formula I include, but are not limited to, those described herein below. Aryl acrylic monomers of Formula I can be obtained from commercial suppliers or, alternatively, manufactured according to methods known in the art.
[0107] A preferred aryl acrylic monomer of formula I is B1 which is OCH2CH2, (OCH2CH2)2, (OCH2CH2)3, or (CH2) m1 (m1 is 2 to 5), Y1 is a direct bond or O, w1 is 0 or 1, and D1 is H, most preferably 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; and corresponding methacrylates.
[0108] Aryl acrylic monomers of Formula II can be prepared from monofunctional (i.e., having a single functional group such as a hydroxyl, amino, or carboxyl group) polyphenyl ethers. Generally, monofunctional OH-terminated poly(phenyl ethers) are reacted with (meth)acrylic acid derivatives (e.g., acryloyl chloride, methacryloyl chloride, methacrylic anhydride, or isocyanatoalkyl acrylate or methacrylate) under coupling reaction conditions known to those skilled in the art. In a similar manner, mono-amine and mono-carboxylic acid-terminated polyphenyl ethers are functionalized using suitable (meth)acrylic acid derivatives. Monofunctional terminal polyphenyl ethers are [referenced in the literature] ( J. Org. Chem. , 1960 It can be manufactured according to the procedure described in , 25(9), pp 1590-1595). Experimental procedures for preparing aryl acrylic monomers of Formula II can be found in U.S. Patent No. 10064977.
[0109] In addition, it should be understood that any type of hydrophobic vinyl monomer can be used as a substitute for hydrophobic acrylic monomers if it contains one or more H-bond acceptors, such as ester bonds, amide bonds, carbonate bonds, carbamate bonds, ether bonds, or combinations thereof. Examples of such hydrophobic monomers include vinyl alkanoates (any one described herein), vinyloxyalkanes (any one described herein), and combinations thereof.
[0110] It should be understood that the mole percentage of each component in the hydrophobic cross-linked acrylic material can be calculated based on the mole percentage of the corresponding polymerizable component (material) in the composition for forming the insert for manufacturing the insert.
[0111] According to the present invention, a hydrophobic crosslinked acrylic material comprises repeating units of one or more vinyl crosslinkers. Any suitable vinyl crosslinker may be used in the present invention. Examples of preferred vinyl crosslinkers include, but are not limited to, acrylic crosslinkers (crosslinkers) (any one described below in this invention), allyl methacrylate, allyl acrylate, aryl crosslinkers (e.g., divinylbenzene, 2-methyl-1,4-divinylbenzene, bis(4-vinylphenyl)methane, 1,2-bis(4-vinylphenyl)ethane, etc.), trialyl isocyanurate, 2,4,6-triallyloxy-1,3,5-triazine, 1,2,4-trivinylcyclohexane, and combinations thereof. It should be understood that vinyl crosslinkers are necessary to impart the target hardness to the crosslinked polymer material of the hard hydrophobic insert.
[0112] In a preferred embodiment, the hydrophobic cross-linked acrylic material comprises a repeating unit of one or more acrylic crosslinking agents (any one of which is described below).
[0113] In another preferred embodiment, the hydrophobic crosslinked acrylic material comprises a repeating unit of one or more aryl crosslinking agents (any one of which is described below).
[0114] In another preferred embodiment, the hydrophobic crosslinked acrylic material comprises one or more repeating units of vinyl-functional polysiloxane, wherein the vinyl-functional polysiloxane comprises two or more vinyl groups directly attached to one silicon atom and 15 mol% or more of siloxane units (each unit having one or more phenyl substituents).
[0115] Examples of such vinyl-functional polysiloxanes include, but are not limited to, vinyl-terminated polyphenylmethylsiloxane (e.g., PMV9925 of Gelest), vinylphenylmethyl-terminated phenylmethyl-vinylphenylsiloxane copolymer (e.g., PVV-3522 of Gelest), vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer (e.g., PDV-1625 of Gelest), or combinations thereof. Preferably, the vinyl-functional polysiloxane is vinyl-terminated polyphenylmethylsiloxane (e.g., PMV9925 of Gelest), vinylphenylmethyl-terminated phenylmethyl-vinylphenylsiloxane copolymer (e.g., PVV-3522 of Gelest), or a combination thereof.
[0116] A composition for forming an insert can be prepared by mixing all of the aforementioned polymer materials with one or more polymerization initiators (thermal polymerization initiators or photoinitiators) in desired proportions in the presence or, preferably, in the absence of a non-reactive organic solvent (i.e., a non-reactive diluent) described herein below.
[0117] Any thermal polymerization initiator may be used in the present invention. Suitable thermal polymerization initiators are known to those skilled in the art and include, for example, peroxides, hydroperoxides, azo-bis(alkyl- or cycloalkylnitrile), persulfates, percarbonates, or mixtures thereof.Examples of preferred thermal polymerization initiators include benzoyl peroxide, t-butyl peroxide, t-amyl peroxybenzoate, 2,2-bis(tert-butylperoxy)butane, 1,1-bis(tert-butylperoxy)cyclohexane, 2,5-bis(tert-butylperoxy)-2,5-dimethylhexane, 2,5-bis(tert-butylperoxy)-2,5-dimethyl-3-hexine, bis(1-(tert-butylperoxy)-1-methylethyl)benzene, 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane, di-t-butyl-diperoxyphthalate, t-butyl hydroperoxide, t-butyl peracetate, t-butyl peroxybenzoate, t-butylperoxyisopropyl carbonate, and acetyl Peroxide, lauroyl peroxide, decanoyl peroxide, dicetyl peroxydicarbonate, di(4-t-butylcyclohexyl)peroxydicarbonate (Perkadox 16S), di(2-ethylhexyl)peroxydicarbonate, t-butylperoxypivalate (Lupersol 11), t-butylperoxy-2-ethylhexanoate (Trigonox 21-C50), 2,4-pentanedione peroxide, dicumyl peroxide, peracetic acid, potassium persulfate, sodium persulfate, ammonium persulfate, 2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile) (VAZO 33), 2,2'-azobis[2-(2-imidazoline-2-yl)propane]dihydrochloride (VAZO 44), 2,2'-azobis(2-amidinopropane) dihydrochloride (VAZO 50), 2,2'-azobis(2,4-dimethylvaleronitrile) (VAZO 52), 2,2'-azobis(isobutyronitrile) (VAZO 64 or AIBN), 2,2'-azobis-2-methylbutyronitrile (VAZO 67), 1,1-azobis(1-cyclohexanecarbonitrile) (VAZO 88), 2,2'-azobis(2-cyclopropylpropionitrile), 2,2'-azobis(methylisobutyrate), 4,4'-azobis(4-cyanovaleric acid), and combinations thereof are included but not limited thereto. Preferably, the thermal initiator is 2,2'-azobis(isobutyronitrile) (AIBN or VAZO 64).
[0118] Suitable photoinitiators include benzoin methyl ether, diethoxyacetophenone, benzoyl-phosphine oxide, 1-hydroxycyclohexyl phenyl ketone, and Darocur type and Irgacur type, preferably Darocur 1173 ® and Darocur 2959 ® There are germanium-based Norrish type I photoinitiators (e.g., those described in U.S. Patent No. 7605190). Examples of benzoylphosphine initiators include 2,4,6-trimethylbenzoyldiphenylophosphine oxide, bis-(2,6-dichlorobenzoyl)-4-N-propylphenyl-phosphine oxide, and bis-(2,6-dichlorobenzoyl)-4-N-butylphenylphosphine oxide. Additionally, reactive photoinitiators that can be incorporated into macromonomers, for example, or used as special monomers are also suitable. Examples of reactive photoinitiators include those disclosed in European Patent No. 632329.
[0119] According to the present invention, the bulk hydrogel material (produced from a lens-forming composition) may be a non-silicone hydrogel material (any one described below in this invention), or preferably a silicone hydrogel material (any one described below in this invention).
[0120] A non-silicon hydrogel material may be produced from a polymerizable composition (e.g., a polymerizable composition for forming a non-silicon hydrogel contact lens). Typically, a polymerizable composition for producing a non-silicon hydrogel material is a monomer mixture comprising (1) (a) one or more hydrophilic vinyl monomers (e.g., hydroxyl-containing vinyl monomers, N-vinylpyrrolidone, or combinations thereof) and (b) one or more components selected from the group consisting of a crosslinking agent, a hydrophobic vinyl monomer, a free radical initiator (photoinitiator or thermal initiator), a UV-absorbing vinyl monomer, a HEVL (high-energy-violet-light) absorbing vinyl monomer, a visibility tinting agent, and combinations thereof; or (2) an aqueous solution comprising one or more components selected from the group consisting of (a) one or more water-soluble prepolymers and (b) a hydrophilic vinyl monomer, a crosslinking agent, a hydrophobic vinyl monomer, a lubricant (or a so-called internal wetting agent incorporated into a lens formulation), a free radical initiator (a photoinitiator or a thermal initiator), a UV-absorbing vinyl monomer, a HEVL-absorbing vinyl monomer, a visibility dye, and combinations thereof.
[0121] Examples of water-soluble prepolymers include water-soluble crosslinkable poly(vinyl alcohol) prepolymers described in U.S. Patents No. 5583163 and 6303687; water-soluble vinyl group-terminated polyurethane prepolymers described in U.S. Patent No. 6995192; derivatives of polyvinyl alcohol, polyethyleneimine, or polyvinylamine disclosed in U.S. Patent No. 5849841; water-soluble crosslinkable polyurea prepolymers described in U.S. Patents No. 6479587 and 7977430; crosslinkable polyacrylamide prepolymers; crosslinkable statistical copolymers of vinyl lactam, MMA, and comonomers disclosed in U.S. Patent No. 5712356; and crosslinkable copolymers of vinyl lactam, vinyl acetate, and vinyl alcohol disclosed in U.S. Patent No. 5665840. Polyether-polyester copolymer having crosslinkable side chains disclosed in U.S. Patent No. 6492478; branched polyalkylene glycol-urethane prepolymer disclosed in U.S. Patent No. 6165408; polyalkylene glycol-tetra(meth)acrylate disclosed in U.S. Patent No. 6221303; and crosslinkable polyallylamine gluconolactone prepolymer disclosed in U.S. Patent No. 6472489 are included, but not limited thereto.
[0122] Numerous types of polymerizable compositions for producing non-silicon hydrogel materials are described in various patents and patent applications disclosed on the filing date of this application and have been used to manufacture commercially available non-silicon hydrogel contact lenses. Examples of commercially available non-silicone hydrogel contact lenses include alfafilcon A, acofilcon A, deltafilcon A, etafilcon A, focofilcon A, helfilcon A, helfilcon B, hilafilcon B, hioxifilcon A, hioxifilcon B, hioxifilcon D, metafilcon A, metafilcon B, nelfilcon A, nesofilcon A, ocufilcon A, ocufilcon B, ocufilcon C, ocufilcon D, omafilcon A, pemfilcon A, polymacon, and samfilcon A. Telfilcon A, tetrafilcon A, and vifilcon A are included but not limited thereto. These can be used as lens-forming compositions of the present invention.
[0123] Preferably, the non-silicone hydrogel material comprises one or more hydroxyl-containing vinyl monomers, preferably selected from the group consisting of hydroxyethyl (meth)acrylate, glycerol (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-amino-2-hydroxypropyl (meth)acrylate, N-2-hydroxyethyl (meth)acrylamide, N-3-hydroxypropyl (meth)acrylamide, N-2-hydroxypropyl (meth)acrylamide, N-2,3-dihydroxypropyl (meth)acrylamide, N-tris(hydroxymethyl)methyl (meth)acrylamide, vinyl alcohol, allyl alcohol, and combinations thereof, more preferably selected from the group consisting of hydroxyethyl (meth)acrylate, glycerol (meth)acrylate, and vinyl alcohol. It contains 50 mol% or more of repeating units.
[0124] Silicone hydrogel materials can be produced from polymerizable compositions (e.g., polymerizable compositions for forming silicone hydrogel contact lenses). A number of polymerizable compositions for producing silicone hydrogel materials are described in several patents and patent applications disclosed on the filing date of this application and have been used to manufacture commercially available SiHy contact lenses. Examples of commercially available SiHy contact lenses include, but are not limited to, asmofilcon A, balafilcon A, comfilcon A, delefilcon A, efrofilcon A, enfilcon A, fanfilcon A, gallyfilcon A, lotrafilcon A, lotrafilcon B, narafilcon A, narafilcon B, senofilcon A, senofilcon B, senofilcon C, smafilcon A, somofilcon A, and stenfilcon A. These may be used as lens-forming compositions of the present invention.
[0125] Preferably, the silicone hydrogel material comprises (a) one or more repeating units of a first polysiloxane vinyl-based crosslinker having hydrophilic siloxane units each having one organic radical (preferably one or more H-bond donors, which are hydroxyl groups) and one methyl substituent, and (b) one or more repeating units of a hydrophilic vinyl monomer, wherein the content of the one or more H-bond donors is about 0.8 meq / g or more (preferably about 1.0 meq / g or more, more preferably about 1.2 meq / g or more, even more preferably about 1.4 meq / g or more) based on the molecular weight of the one or more first polysiloxane vinyl-based crosslinker.
[0126] According to the present invention, any type of polysiloxane vinyl crosslinking agent may be used as the first polysiloxane vinyl crosslinking agent in the present invention if it has hydrophilic siloxane units comprising one organic radical (preferably one or more H-bond donors, which are hydroxyl groups) and one methyl substituent in each unit. Examples of a preferred class of polysiloxane vinyl crosslinking agents include dimethylsiloxane units and one monovalent C4-C (each unit having 2 to 6 hydroxyl groups). 40 Examples include di-(meth)acryloyloxy-terminated polysiloxane vinyl crosslinkers having hydrophilic siloxane units (containing an organic radical substituent and one methyl substituent), and more preferably, polysiloxane vinyl crosslinkers of formula (G) described below. These can be prepared according to the procedure disclosed in U.S. Patent No. 10081697.
[0127] Any hydrophilic vinyl monomer may be used in the present invention. Examples of preferred hydrophilic vinyl monomers include alkyl (meth)acrylamide (described below), hydroxyl-containing acrylic monomer (described below), amino-containing acrylic monomer (described below), carboxyl-containing acrylic monomer (described below), N-vinylamide monomer (described below), methylene-containing pyrrolidone monomer (described below) (i.e., pyrrolidone derivatives in which a methylene group is connected to a pyrrolidone ring at the 3rd or 5th position, respectively), acrylic monomer having a C1-C4 alkoxyethoxy group (described below), vinyl ether monomer (described below), allyl ether monomer (described below), phosphorylcholine-containing vinyl monomer (described below), and N-2-hydroxyethyl Examples include vinyl carbamate, N-carboxyvinyl-β-alanine (VINAL), N-carboxyvinyl-α-alanine, and combinations thereof.
[0128] According to the present invention, the silicone hydrogel material may further comprise repeating units of a silicone-containing vinyl monomer and / or repeating units of a second polysiloxane vinyl crosslinking agent (different from the first polysiloxane vinyl crosslinking agent).
[0129] According to the present invention, the silicon-containing vinyl monomer may be any silicon-containing vinyl monomer known to those skilled in the art. Examples of preferred silicon-containing vinyl monomers include, but are not limited to, vinyl monomers having a bis(trialkylsilyloxy)alkylsilyl group, vinyl monomers having a tris(trialkylsilyloxy)silyl group, polysiloxane vinyl monomers, 3-methacryloxypropylpentamethyldisiloxane, t-butyldimethylsiloxyethyl vinyl carbonate, trimethylsilylethyl vinyl carbonate, trimethylsilylmethyl vinyl carbonate, and combinations thereof.
[0130] As described below herein, preferred polysiloxane vinyl monomers, including polysiloxane vinyl monomers of formula M1, may be obtained from commercial suppliers (e.g., Shin-Etsu, Gelest, etc.); may be prepared according to the procedures described in various patent documents, e.g., U.S. Patents No. 5070215, No. 6166236, No. 6867245, No. 8415405, No. 8475529, No. 8614261, and No. 9217813; or may be prepared by reacting a hydroxyalkyl (meth)acrylate or (meth)acrylamide or (meth)acryloxypolyethylene glycol with a mono-epoxypropyloxypropyl terminal polydimethylsiloxane; Glycidyl (meth)acrylate can be prepared by reacting it with mono-carbinol-terminated polydimethylsiloxane, mono-aminopropyl-terminated polydimethylsiloxane, or mono-ethylaminopropyl-terminated polydimethylsiloxane; or isocyanatoethyl (meth)acrylate can be prepared by reacting it with mono-carbinol-terminated polydimethylsiloxane according to a coupling reaction well known to those skilled in the art.
[0131] As described below in this document, preferred silicon-containing vinyl monomers (each containing a bis(trialkylsilyloxy)alkylsilyl group or a tris(trialkylsilyloxy)silyl group), including the silicon-containing vinyl monomer of formula M2, can be obtained from commercial suppliers (e.g., Shin-Etsu, Gelest, etc.); or can be manufactured according to the procedures described in several patent documents, e.g., U.S. Patents No. 5070215, 6166236, 7214809, 8475529, 8658748, 9097840, 9103965, and 9475827.
[0132] Any suitable polysiloxane vinyl crosslinking agent may be used as a second polysiloxane vinyl crosslinking agent in the present invention. Examples of polysiloxane vinyl crosslinking agents preferred as the second polysiloxane vinyl crosslinking agent include di-(meth)acryloyl-terminated polydimethylsiloxane; di-vinyl carbonate-terminated polydimethylsiloxane; di-vinyl carbamate-terminated polydimethylsiloxane; N,N,N',N'-tetrakis(3-methacryloxy-2-hydroxypropyl)-α,ω-bis-3-aminopropyl-polydimethylsiloxane; and a polysiloxane-containing macromonomer selected from the group consisting of macromonomer A, macromonomer B, macromonomer C, and macromonomer D as described in U.S. Patent No. 5,760,100. U.S. Patents No. 4136250, 4153641, 4182822, 4189546, 4343927, 4254248, 4355147, 4276402, 4327203, 4341889, 4486577, 4543398, 4605712, 4661575, 4684538, 4703097, 4833218, 4837289, 4954586, 4954587, 5010141, 5034461, 5070170, 5079319, Examples include polysiloxane-containing macromonomers disclosed in No. 5039761, No. 5346946, No. 5358995, No. 5387632, No. 5416132, No. 5451617, No. 5486579, No. 5962548, No. 5981675, No. 6039913 and No. 6762264; polysiloxane-containing macromonomers disclosed in U.S. Patents No. 4259467, No. 4260725 and No. 4261875.
[0133] A class of preferred polysiloxane vinyl crosslinking agents is a vinyl crosslinking agent, each comprising one homogeneous polydiorganosiloxane segment and two terminal (meth)acryloyl groups. Such vinyl crosslinking agents may be available from commercial suppliers; may be prepared by reacting glycidyl (meth)acrylate (meth)acryloyl chloride with di-amino-terminal polydimethylsiloxane or di-hydroxyl-terminal polydimethylsiloxane; may be prepared by reacting isocyanatoethyl (meth)acrylate with di-hydroxyl-terminal polydimethylsiloxane; or may be prepared by reacting an amino-containing acrylic monomer with di-carboxyl-terminal polydimethylsiloxane in the presence of a coupling agent (carbodiimide); It can be prepared by reacting a carboxyl-containing acrylic monomer with a di-amino-terminal polydimethylsiloxane in the presence of a coupling agent (carbodiimide); or by reacting a hydroxyl-containing acrylic monomer with a di-hydroxy-terminal polydisiloxane in the presence of a diisocyanate or a di-epoxy coupling agent.
[0134] Another class of polysiloxane vinyl crosslinkers preferred as a second polysiloxane vinyl crosslinker is a chain-extended polysiloxane vinyl crosslinker, each having two terminal ethylenically unsaturated groups and two or more polydiorganosiloxane segments (each pair of polydiorganosiloxane segments is connected by a single linker). Such chain-extended polysiloxane vinyl crosslinkers can be manufactured according to the procedures described in U.S. Patents No. 5034461, 5416132, 5449729, 5760100, 7423074, 8529057, 8835525, 8993651, 10301451, and 10465047.
[0135] According to the present invention, the silicone hydrogel material may also comprise one or more repeating units of hydrophobic non-silicon vinyl monomers. Examples of preferred hydrophobic non-silicon vinyl monomers include non-silicon hydrophobic acrylic monomers (e.g., methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, cyclohexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, isobornyl (meth)acrylate, (meth)acrylonitrile, etc.), and fluorine-containing acrylic monomers (e.g., perfluorohexylethyl-thio-carbonyl-aminoethyl-methacrylate, perfluoro-substituted C2-C 12 Examples include alkyl (meth) acrylates, etc. (described later), vinyl alkanoates (e.g., vinyl acetate, vinyl propionate, vinyl butyrate, vinyl valerate, etc.), vinyl oxyalkanes (e.g., vinyl ethyl ether, propyl vinyl ether, n-butyl vinyl ether, isobutyl vinyl ether, cyclohexyl vinyl ether, t-butyl vinyl ether, etc.), styrene, vinyl toluene, vinyl chloride, vinylidene chloride, 1-butene, and combinations thereof.
[0136] Any suitable perfluorosubstituted C2-C 12 Alkyl (meth)acrylates may be used in the present invention. Perfluoro-substituted C2-C 12 Examples of alkyl (meth)acrylates include, but are not limited to, 2,2,2-trifluoroethyl (meth)acrylate, tetrafluoropropyl (meth)acrylate, hexafluoro-iso-propyl (meth)acrylate, hexafluorobutyl (meth)acrylate, heptafluorobutyl (meth)acrylate, octafluoropentyl (meth)acrylate, heptadecafluorodecyl (meth)acrylate, pentafluorophenyl (meth)acrylate.
[0137] According to the present invention, the silicone hydrogel material may also include one or more repeating units of a non-silicon vinyl-based crosslinking agent. Examples of preferred non-silicon vinyl-based crosslinking agents will be described herein below.
[0138] According to the present invention, the silicone hydrogel material may also include repeating units of other polymeric materials, such as UV-absorbing vinyl monomers, UV / HEVL-absorbing vinyl monomers, polymerizable photochromic compounds, polymerizable dyes (polymerizable dyes), or combinations thereof, which are known to those skilled in the art.
[0139] Any suitable UV-absorbing vinyl monomer and UV / HEVL-absorbing vinyl monomer may be used in the polymerizable composition for manufacturing the preformed SiHy contact lens of the present invention. Examples of preferred UV-absorbing vinyl monomers and UV / HEVL-absorbing vinyl monomers include 2-(2-hydroxy-5-vinylphenyl)-2H-benzotriazole, 2-(2-hydroxy-5-acrylyloxyphenyl)-2H-benzotriazole, 2-(2-hydroxy-3-methacrylamidomethyl-5-tert-octylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-methoxybenzotriazole, and 2-(2'-hydroxy-5'-methacryloxypropyl-3'-t-butyl-phenyl)-5-chlorobenzotriazole. 2-(2'-hydroxy-5'-methacryloxypropylphenyl)benzotriazole, 2-hydroxy-5-methoxy-3-(5-(trifluoromethyl)-2H-benzo[d][1,2,3]triazole-2-yl)benzyl methacrylate (WL-1), 2-hydroxy-5-methoxy-3-(5-methoxy-2H-benzo[d][1,2,3]triazole-2-yl)benzyl methacrylate (WL-5), 3-(5-fluoro-2H-benzo[d][1,2,3]triazole-2-yl)-2-hydroxy-5-methoxybenzyl methacrylate (WL-2), 3-(2H-benzo[d][1,2,3]triazole-2-yl)-2-hydroxy-5-methoxybenzyl methacrylate (WL-3), 3-(5-chloro-2H-benzo[d][1,2,3]triazole-2-yl)-2-hydroxy-5-methoxybenzyl methacrylate (WL-4), 2-hydroxy-5-methoxy-3-(5-methyl-2H-benzo[d][1,2,3]triazole-2-yl)benzyl methacrylate (WL-6), 2-hydroxy-5-methyl-3-(5-(trifluoromethyl)-2H-benzo[d][1,2,3]triazole-2-yl)benzyl methacrylate (WL-7), 4-allyl-2-(5-chloro-2H-benzo[d][1,2,3]triazole-2-yl)-6-methoxyphenol (WL-8), 2-{2'-hydroxy-3'-tert-5'[3"-(4"-vinylbenzyloxy)propoxy]phenyl}-5-methoxy-2H-benzotriazole, phenol,2-(5-chloro-2H-benzotriazole-2-yl)-6-(1,1-dimethylethyl)-4-ethenyl-(UVAM), 2-[2'-hydroxy-5'-(2-methacryloyloxyethyl)phenyl]-2H-benzotriazole(2-propenic acid, 2-methyl-, 2-[3-(2H-benzotriazole-2-yl)-4-hydroxyphenyl]ethyl ester, Norbloc), 2-{2'-hydroxy-3'-tert-butyl-5'-[3'-methacryloyloxypropoxy]phenyl}-2H-benzotriazole, 2-{2'-hydroxy-3'-tert-butyl-5'-[3'-methacryloyloxypropoxy]phenyl}-5-methoxy-2H-benzotriazole (UV13), 2-{2'-hydroxy-3'-tert-butyl-5'-[3'-methacryloyloxypropoxy]phenyl}-5-chloro-2H-benzotriazole (UV28), 2-[2'-hydroxy-3'-tert-butyl-5'-(3'-acryloyloxypropoxy)phenyl]-5-trifluoromethyl-2H-benzotriazole (UV23), 2-(2'-hydroxy-5-methacrylamidophenyl)-5-methoxybenzotriazole (UV6), 2-(3-allyl-2-hydroxy-5-methylphenyl)-2H-benzotriazole (UV9), 2-(2-hydroxy-3-metallyl-5-methylphenyl)-2H-benzotriazole (UV12), 2-3'-t-butyl-2'-hydroxy-5'-(3"-dimethylvinylsilylpropoxy)-2'-hydroxy-phenyl)-5-methoxybenzotriazole (UV15), 2-(2'-hydroxy-5'-methacryloylpropyl-3'-tert-butyl-phenyl)-5-methoxy-2H-benzotriazole (UV16), 2-(2'-hydroxy-5'-acryloylpropyl-3'-tert-butyl-phenyl)-5-methoxy-2H-benzotriazole (UV16A), 2-methylacrylic acid 3-[3-tert-butyl-5-(5-chlorobenzotriazole-2-yl)-4-hydroxyphenyl]-propyl ester (16-100, CAS#96478-15-8), 2-(3-(tert-butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d][1,2,3]triazole-2-yl)phenoxy)ethyl methacrylate (16-102); phenol, 2-(5-chloro-2, H-benzotriazole-2-yl)-6-methoxy-4-(2-propene-1-yl) (CAS# 1260141-20-5); 2-[2-hydroxy-5-[3-(methacryloyloxy)propyl]-3-tert-butylphenyl]-5-chloro-2H-benzotriazole; phenol, 2-(5-ethenyl-2H-benzotriazole-2-yl)-4-methyl-, homopolymer (9CI) (CAS#83063-87-0) are included but not limited thereto. According to the present invention, the polymerizable composition comprises one or more UV-absorbing vinyl monomers in an amount of about 0.1% to about 3.0% by weight, preferably about 0.2% to about 2.5% by weight, more preferably about 0.3% to about 2.0% by weight, based on the amount of all polymerizable components in the polymerizable composition.
[0140] Examples of preferred photochromic vinyl monomers include polymerizable naphtopyran, polymerizable benzopyran, polymerizable indenonaphtopyran, and polymerizable phenantropyran disclosed in U.S. Patents No. 4929693, 5166345, 6017121, 7556750, 7584630, 7999989, 8158037, 8697770, 8741188, 9052438, 9097916, 9465234, 9904074, 10197707, 6019914, 6113814, 6149841, 6296785, and 6348604. Polymerizable spiro(benzindolin)-naphtopyran, polymerizable spiro(indolin)benzopyran, polymerizable spiro(indolin)-naphtopyran, polymerizable spiro(indolin)quinopyran, polymerizable spiro(indolin)-pyran, polymerizable naphthoxane, polymerizable spirobenzopyran; polymerizable spirobenzopyran, polymerizable spirobenzothiopyran, polymerizable naphthacendione, polymerizable spiroxane, polymerizable spiro(indolin)naphthoxane, polymerizable spiro(indolin)pyridobenzoxane, polymerizable spiro(benzindolin)pyridobenzoxane, polymerizable spiro(benzindolin)naphthoxane, polymerizable spiro(indolin)benzoxane, polymerizable diarylethene, and combinations thereof are included.
[0141] In a preferred embodiment, the silicone hydrogel material comprises about 5 weight% or more of a repeating unit of a first polysiloxane vinyl-based crosslinking agent (preferably about 10 weight% or more, more preferably about 15 weight% or more, even more preferably about 20 weight% or more, most preferably about 25 weight% or more).
[0142] According to the present invention, the silicone hydrogel material has an equilibrium water content (i.e., water content when fully hydrated or being fully hydrated) of about 20 wt% to about 70 wt% (preferably about 20 wt% to about 65 wt%, more preferably about 25 wt% to about 65 wt%, even more preferably about 30 wt% to about 60 wt%), an oxygen permeability of about 40 times or more (preferably about 60 times or more, more preferably about 80 times or more, even more preferably about 100 times or more), and an elastic modulus (i.e., Young's modulus) of about 1.5 MPa or less (preferably about 0.2 MPa to about 1.2 MPa, more preferably about 0.3 MPa to about 1.1 MPa, even more preferably about 0.4 MPa to about 1.0 MPa).
[0143] A composition for forming a lens or a composition for forming an insert (i.e., a polymerizable composition) may be a solvent-free clear liquid prepared by mixing all polymerizable components (or substances) and other necessary components (or substances), or a solution prepared by dissolving all desired components (or substances) in any suitable solvent (e.g., a mixture of water and one or more organic solvents miscible with water as known to those skilled in the art, an organic solvent, or a mixture of one or more organic solvents). (The term “solvent” in any of the following descriptions in this application refers to a chemical substance that cannot participate in free radical polymerization reactions.)
[0144] Generally, solvent-free polymerizable compositions comprise one or more blending vinyl monomers as reactive solvents for dissolving all other polymerizable components. Examples of preferred blending vinyl monomers will be described below. Preferably, methyl methacrylate is used as the blending vinyl monomer when preparing the solvent-free polymerizable composition.
[0145] Examples of suitable solvents include acetone, methanol, cyclohexane, tetrahydrofuran, tripropylene glycol methyl ether, dipropylene glycol methyl ether, ethylene glycol n-butyl ether, ketones (e.g., acetone, methyl ethyl ketone, etc.), diethylene glycol n-butyl ether, diethylene glycol methyl ether, ethylene glycol phenyl ether, propylene glycol methyl ether, propylene glycol methyl ether acetate, dipropylene glycol methyl ether acetate, propylene glycol n-propyl ether, dipropylene glycol n-propyl ether, tripropylene glycol n-butyl ether, propylene glycol n-butyl ether, dipropylene glycol n-butyl ether, tripropylene glycol n-butyl ether, propylene glycol phenyl ether, dipropylene glycol dimethyl ether, polyethylene glycol, Polypropylene glycol, ethyl acetate, butyl acetate, amyl acetate, methyl lactate, ethyl lactate, i-propyl lactate, methylene chloride, 2-butanol, 1-propanol, 2-propanol, menthol, cyclohexanol, cyclopentanol and exonorborneol, 2-pentanol, 3-pentanol, 2-hexanol, 3-hexanol, 3-methyl-2-butanol, 2-heptanol, 2-octanol, 2-nonanol, 2-decanol, 3-octanol, norborneol, tert-butanol, tert-amyl alcohol, 2-methyl-2-pentanol, 2,3-dimethyl-2-butanol, 3-methyl-3-pentanol, 1-methylcyclohexanol, 2-methyl-2-hexanol, 3,7-dimethyl-3-octanol, 1-chloro-2-methyl-2-propanol, 2-methyl-2-heptanol, 2-methyl-2-octanol, 2-2-methyl-2-nonanol, 2-methyl-2-decanol, 3-methyl-3-hexanol, 3-methyl-3-heptanol, 4-methyl-4-heptanol, 3-methyl-3-octanol, 4-methyl-4-octanol, 3-methyl-3-nonanol, 4-methyl-4-nonanol, 3-methyl-3-octanol, 3-ethyl-3-hexanol, 3-methyl-3-heptanol, 4-ethyl-4-heptanol, 4-propyl-4-heptanol, 4-isopropyl-4-heptanol, 2,4-dimethyl-2-pentanol, 1-Methylcyclopentanol, 1-Ethylcyclopentanol,1-ethylcyclopentanol, 3-hydroxy-3-methyl-1-butene, 4-hydroxy-4-methyl-1-cyclopentanol, 2-phenyl-2-propanol, 2-methoxy-2-methyl-2-propanol, 2,3,4-trimethyl-3-pentanol, 3,7-dimethyl-3-octanol, 2-phenyl-2-butanol, 2-methyl-1-phenyl-2-propanol, 3-ethyl-3-pentanol, 1-ethoxy-2-propanol, 1-methyl-2-propanol, t-amyl alcohol, isopropanol, 1-methyl-2-pyrrolidone, N,N-dimethylpropionamide, dimethylformamide, dimethylacetamide, dimethylpropionamide, N-methylpyrrolidinone, and mixtures thereof are included. Examples of more preferred organic solvents include, but are not limited to, methanol, ethanol, 1-propanol, isopropanol, sec-butanol, tert-butyl alcohol, tert-amyl alcohol, acetone, methyl ethyl ketone, methyl isopropyl ketone, methyl propyl ketone, ethyl acetate, heptane, methylhexane (various isomers), methylcyclohexane, dimethylcyclopentane (various isomers), 2,2,4-trimethylpentane, and mixtures thereof.
[0146] The composition for forming an insert and the composition for forming a lens can be introduced into the insert-forming cavity and the lens-forming cavity, respectively, according to any technique known to those skilled in the art.
[0147] The step of curing the polymerizable composition inside the insert-molding or lens-molding cavity of the mold can be performed thermally (i.e., by heating) or by chemical irradiation (i.e., chemical irradiation, e.g., UV irradiation and / or visible light irradiation) to activate the polymerization initiator.
[0148] Chemical radiation polymerization of a polymerizable composition in a mold can be carried out by irradiating UV or visible light onto a closed mold containing the polymerizable composition according to any technique known to those skilled in the art.
[0149] As is well known to those skilled in the art, thermal polymerization of the polymerizable composition in the mold can be conveniently carried out in an oven at a temperature of 25°C to 120°C, preferably 40°C to 100°C. The reaction time can be varied within a wide range, but conveniently, for example, 1 hour to 24 hours or preferably 2 hours to 12 hours. It is advantageous to carry out the aforementioned copolymerization reaction under an inert atmosphere, such as nitrogen or argon, after the silicone-hydrogel-lens forming composition has been degassed beforehand.
[0150] Following the curing step and optionally the post-curing step, the step of opening the mold (i.e., separating the female half-mold and the male half-mold while the unprocessed ocular silicone hydrogel contact lens is attached to one of the female half-mold or the male half-mold) and the step of separating the lens (i.e. separating the unprocessed ocular silicone hydrogel contact lens from the half-mold to which the lens is attached) are performed according to any technique known to those skilled in the art.
[0151] After separating the unprocessed intravitreal silicone hydrogel contact lens, extraction is performed using a liquid extraction medium that is generally well known to those skilled in the art. The liquid extraction medium is a solvent capable of dissolving the diluent(s), unpolymerized polymer material, and oligomer within the unprocessed intravitreal silicone hydrogel contact lens. Water, any organic solvent known to those skilled in the art, or a mixture thereof may be used in the present invention. Preferably, the organic solvent used as the extraction liquid medium is water, buffered saline, C1-C3 alkyl alcohol, 1,2-propylene glycol, polyethylene glycol having a number average molecular weight of about 400 daltons or less, C1-C6 alkyl alcohol, or a combination thereof.
[0152] Next, the extracted intraocular hydrogel contact lens can be hydrated according to any method known to those skilled in the art.
[0153] Hydrated intraocular hydrogel contact lenses may undergo additional processes such as, for example, surface treatment, packaging in a lens package containing a preservation solution well known to those skilled in the art, and sterilization (e.g., autoclave) at 118°C to 124°C for at least about 30 minutes.
[0154] Lens packages (or packaging containers) are well known to those skilled in the art as being used for autoclaving and storing soft contact lenses. Any lens package may be used in the present invention. Preferably, the lens package is a blister package comprising a base and a cover, wherein the cover is detachably sealed to the base and a cavity is formed in the base to receive a sterile lens solution and a contact lens.
[0155] Before being provided to a user, the lenses are packaged in individual packages and sealed, and then sterilized (e.g., in an autoclave at about 120°C or higher under pressure for at least 30 minutes). Those skilled in the art are well aware of the methods for sealing and sterilizing lens packages.
[0156] Although various embodiments of the present invention have been described using specific terms, devices, and methods, such description is for illustrative purposes only. The words used herein are for illustrative purposes only and are not limiting. As will be apparent to those skilled in the art, the present invention can be modified and altered in various ways without departing from the spirit and scope of the novel concepts of this disclosure. Furthermore, it should be understood that various embodiments of the present invention may be shared interchangeably, in whole or in part, or combined and / or used together in any manner, as exemplified below:
[0157] 1. (1) A step of generating a magnetized insert having a diameter of about 13.0 mm or less, a front surface and a rear surface opposite to it, wherein the insert is made of a polymer material and contains magnetic particles;
[0158] (2) A lens molding step comprising a female half-mold having a first molding surface and a male half-mold having a second molding surface, wherein the female half-mold and the male half-mold are configured to accommodate each other so that a cavity is formed between the first molding surface and the second molding surface when the mold is closed;
[0159] (3) A step of placing a magnetized insert and introducing a lens-forming composition, regardless of the order, in which a magnetized insert is placed in a lens mold and a lens-forming composition is introduced into the lens mold, wherein the magnetized insert is immersed in the lens-forming composition within the lens mold and the magnetized insert is placed in the center of the lens mold and fixed in place using a magnet placed below the lens mold;
[0160] (4) A lens-forming composition curing step in which a lens-forming composition is cured within a lens mold while a magnet is used to fix a magnetized insert in the center of the lens mold to form an unprocessed intraocular hydrogel contact lens, wherein a bulk hydrogel material produced from the lens-forming composition is included in the unprocessed intraocular hydrogel contact lens and a magnetized insert is embedded in the bulk hydrogel material and placed in the center of the unprocessed intraocular hydrogel contact lens;
[0161] (5) A lens mold separation step in which the lens mold produced in step (4) is separated into a female half mold and a male half mold, wherein an unprocessed intraocular hydrogel contact lens is attached to a lens-attaching half mold, which is either the female half mold or the male half mold;
[0162] (6) a step of removing the unprocessed ocular hydrogel contact lens from the lens-attachment half mold (preferably before the unprocessed ocular hydrogel contact lens comes into contact with water or any liquid); and
[0163] (7) A post-forming process including a hydration process on an unprocessed ocular-implantable hydrogel contact lens, and one or more other processes selected from the group consisting of extraction, surface treatment, packaging, sterilization and combinations thereof.
[0164] A method for manufacturing an ocular-implantable hydrogel contact lens comprising
[0165] 2. The method according to Embodiment 1, wherein the curing step (4) of the lens-forming composition is performed by chemical irradiation using UV and / or visible light.
[0166] 3. The method according to Embodiment 1, wherein the curing step (4) of the lens-forming composition is performed thermally by heating the first molding assembly in an oven at one or more curing temperatures selected from about 40°C to about 100°C.
[0167] 4. An ocular hydrogel contact lens comprising an anterior surface, a posterior surface opposite thereto, a bulk hydrogel material, and a magnetized insert embedded in the bulk hydrogel material,
[0168] An intraocular hydrogel contact lens comprising a magnetizing insert made of a polymer material and containing magnetic particles, wherein the magnetizing insert has a diameter of about 13.0 mm or less and has a front surface and a rear surface opposite thereto, wherein the magnetizing insert is located in the central part of the intraocular hydrogel contact lens, and wherein the intraocular hydrogel contact lens is not easily delaminated as evidenced by the absence of microscopically observable bubbles at the interface between the bulk material and the insert within the intraocular silicone hydrogel contact lens after autoclaving in a lens storage solution in a sealed package, and wherein the lens storage solution is a buffered saline solution with a pH of 7.1 ± 0.2.
[0169] 5. An ocular-implantable hydrogel contact lens according to any one of embodiments 1 to 3 or according to embodiment 4, wherein the magnetized implant comprises magnetic particles distributed in the polymer material of the magnetized implant.
[0170] 6. An ocular-implantable hydrogel contact lens according to any one of embodiments 1 to 3 and 5, wherein the magnetizing insert comprises a magnetic coating on either the front or rear surface, and the magnetic coating comprises magnetic particles.
[0171] 7. An ocular-implantable hydrogel contact lens according to any one of embodiments 1 to 3 and 5, wherein the magnetizing insert comprises a magnetic color image printed on either the front or back surface using at least one ink containing magnetic particles, and said magnetic color image contains magnetic particles.
[0172] 8. A method according to Embodiment 7 or an ocular hydrogel contact lens in which the magnetic color image includes an annular ring.
[0173] 9. A method according to any one of embodiments 1 to 3 and 5 to 8 or an ocular hydrogel contact lens according to any one of embodiments 4 to 8, wherein the polymer material of the magnetized insert comprises a repeating unit of one or more polymerizable photochromic compounds (i.e., photochromic vinyl monomers), a repeating unit of one or more UV-absorbing vinyl monomers, a repeating unit of one or more UV / HEVL-absorbing vinyl monomers, a repeating unit of one or more fluorescent vinyl monomers, or a combination thereof.
[0174] 10. An intraocular hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 8, wherein the magnetizing implant comprises one or more color filtering materials for color blindness correction, diffractive materials, high refractive index materials, or combinations thereof.
[0175] 11. An ocular hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 10, wherein the polymer material of the magnetized insert is a hard plastic.
[0176] 12. A method according to Example 11 or an ocular hydrogel contact lens in which the rigid plastic is cross-linked polymethyl methacrylate.
[0177] 13. An ocular hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 10, wherein the polymer material of the magnetized insert is a cross-linked silicone polymer having a stereochemical (3D) polymer network structure, being water-insoluble, and having an equilibrium water content of about 5 weight% or less (preferably about 3 weight% or less, more preferably about 2 weight% or less).
[0178] 14. A method according to Embodiment 13 or an ocular hydrogel contact lens having an equilibrium water content of the cross-linked silicone polymer of about 3 weight% or less (preferably about 2 weight% or less).
[0179] 15. An ocular hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 10, wherein the polymer material of the magnetized insert is a rigid gas-permeable material.
[0180] 16. A method according to any one of embodiments 1 to 3 and 5 to 10 or an ocular hydrogel contact lens according to any one of embodiments 4 to 10, wherein the polymer material of the magnetized insert is a hydrophobic crosslinked acrylic material having an equilibrium water content of less than 5 weight%, containing 55 mol% or more of repeating units of one or more acrylic monomers and / or one or more repeating units of an acrylic crosslinking agent, and containing about 6 mol% or more of repeating units of one or more vinyl crosslinking agents.
[0181] 17. A hydrogel contact lens according to the method of Embodiment 16 or an ocular implantable hydrogel, wherein the equilibrium water content of the hydrophobic cross-linked acrylic material is about 4 weight% or less.
[0182] 18. A hydrogel contact lens according to the method of Embodiment 16 or an ocular implantable hydrogel, wherein the equilibrium water content of the hydrophobic cross-linked acrylic material is about 3 weight% or less.
[0183] 19. A hydrogel contact lens according to the method of Embodiment 16 or an ocular implantable hydrogel, wherein the equilibrium water content of the hydrophobic cross-linked acrylic material is about 2 weight% or less.
[0184] 20. A method according to any one of embodiments 16 to 19 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises about 60 mol% or more of the repeating unit of one or more acrylic monomers and / or the repeating unit of one or more acrylic crosslinking agents.
[0185] 21. A method according to any one of embodiments 16 to 19 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises at least 65 mol% of the repeating unit of one or more acrylic monomers and / or the repeating unit of one or more acrylic crosslinking agents.
[0186] 22. A method according to any one of embodiments 16 to 19 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises about 70 mol% or more of the repeating unit of one or more acrylic monomers and / or the repeating unit of one or more acrylic crosslinking agents.
[0187] 23. A method according to any one of embodiments 16 to 22 or an ocular hydrogel contact lens, wherein the crosslinking polymer material comprises about 8 mol% or more of repeating units of one or more vinyl-based crosslinking agents.
[0188] 24. A method according to any one of embodiments 16 to 22 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises about 10 mol% or more of repeating units of one or more vinyl crosslinking agents.
[0189] 25. A method according to any one of embodiments 16 to 22 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises about 12 mol% or more of repeating units of one or more vinyl crosslinking agents.
[0190] 26. A method according to any one of embodiments 16 to 25 or an ocular-implantable hydrogel contact lens, wherein the one or more vinyl-based crosslinking agents comprises one or more acrylic-based crosslinking agents.
[0191] 27. The above one or more acrylic crosslinking agents are: ethylene glycol dimethacrylate; ethylene glycol diacrylate; 1,3-propanediol diacrylate; 1,3-propanediol dimethacrylate; 2,3-propanediol diacrylate; 2,3-propanediol dimethacrylate; 1,4-butanediol dimethacrylate; 1,4-butanediol diacrylate; 1,5-pentanediol dimethacrylate; 1,5-pentanediol diacrylate; 1,6-hexanediol dimethacrylate; 1,6-hexanediol diacrylate; diethylene glycol dimethacrylate; diethylene glycol diacrylate; triethylene glycol dimethacrylate; triethylene glycol diacrylate; tetraethylene glycol dimethacrylate; Tetraethylene glycol diacrylate; N,N'-methylene bis(acrylamide); N,N'-methylene bis(methacrylamide); N,N'-ethylene bis(acrylamide); N,N'-ethylene bis(methacrylamide); N,N'-hexamethylene bisacrylamide; N,N'-hexamethylene bismethacrylamide; A method according to Embodiment 26 or an intraocular hydrogel contact lens, which is pentaerythritol triacrylate, pentaerythritol trimethacrylate, trimethylloylpropane triacrylate, trimethylloylpropane trimethacrylate, tris(2-hydroxyethyl)isocyanurate triacrylate, tris(2-hydroxyethyl)isocyanurate trimethacrylate, 1,3,5-triacryloxylhexahydro-1,3,5-triazine, 1,3,5-trimethacryloxylhexahydro-1,3,5-triazine; pentaerythritol tetraacrylate, pentaerythritol tetramethacrylate, di(trimethylloylpropane) tetraacrylate, di(trimethylloylpropane) tetramethacrylate, or a combination thereof.
[0192] 28. A method according to Example 26 or an ocular hydrogel contact lens, wherein one or more of the above acrylic crosslinking agents are allyl methacrylate, allyl acrylate, aryl crosslinking agent, trialyl isocyanurate, 2,4,6-triallyloxy-1,3,5-triazine, 1,2,4-trivinylcyclohexane, or a combination thereof.
[0193] 29. One or more acrylic crosslinking agents are divinylbenzene, 2-methyl-1,4-divinylbenzene, bis(4-vinylphenyl)methane, 1,2-bis(4-vinylphenyl)ethane, or a combination thereof, in a method according to Example 26 or an ocular hydrogel contact lens.
[0194] 30. A method according to any one of embodiments 16 to 29 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises repeating units of one or more acrylic monomers, including a silicon-containing acrylic monomer, a non-silicon hydrophobic acrylic monomer, a fluorine-containing acrylic monomer, an aryl acrylic monomer, or a combination thereof.
[0195] 31. A method according to any one of embodiments 16 to 29 or an ocular hydrogel contact lens, wherein the hydrophobic cross-linked acrylic material comprises repeating units of one or more non-silicone hydrophobic acrylic monomers.
[0196] 32. One or more non-silicone hydrophobic acrylic monomers are methyl (meth)acrylate, ethyl (meth)acrylate, propyl (meth)acrylate, isopropyl (meth)acrylate, cyclohexyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, isobornyl (meth)acrylate, (meth)acrylonitrile, or a combination thereof, in a method according to Embodiment 31 or an ocular hydrogel contact lens.
[0197] 33. A method according to any one of embodiments 16 to 32 or an ocular hydrogel contact lens, wherein the hydrophobic cross-linked acrylic material comprises repeating units of one or more fluorine-containing acrylic monomers.
[0198] 34. The method according to Embodiment 33 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned fluorine-containing acrylic monomers are perfluorohexylethyl-thio-carbonyl-aminoethyl-methacrylate, 2,2,2-trifluoroethyl (meth)acrylate, tetrafluoropropyl (meth)acrylate, hexafluoro-iso-propyl (meth)acrylate, hexafluorobutyl (meth)acrylate, heptafluorobutyl (meth)acrylate, octafluoropentyl (meth)acrylate, heptadecafluorodecyl (meth)acrylate, pentafluorophenyl (meth)acrylate, or a combination thereof.
[0199] 35. A method according to any one of embodiments 16 to 34 or an ocular hydrogel contact lens, wherein the hydrophobic cross-linked acrylic material comprises repeating units of one or more silicon-containing acrylic monomers.
[0200] 36. A method according to any one of embodiments 16 to 35 or an ocular hydrogel contact lens, wherein the hydrophobic crosslinked acrylic material comprises repeating units of one or more polysiloxane vinyl-based crosslinking agents.
[0201] 37. A method according to Example 36 or an ocular hydrogel contact lens, wherein each of the above one or more polysiloxane vinyl-based crosslinking agents comprises 30 mol% or more of siloxane units having one or more phenyl substituents.
[0202] 38. A method according to Example 36 or an ocular hydrogel contact lens, wherein each of the above one or more polysiloxane vinyl-based crosslinking agents comprises 60 mol% or more of siloxane units having one or more phenyl substituents.
[0203] 39. A method according to Example 36 or an ocular hydrogel contact lens, wherein each of the above one or more polysiloxane vinyl-based crosslinking agents comprises 90 mol% or more of siloxane units having one or more phenyl substituents.
[0204] 40. A method according to Embodiment 36 or an ocular hydrogel contact lens, wherein the one or more polysiloxane vinyl-based crosslinking agents each comprise three or more vinylphenylsiloxane units having one or more phenyl substituents and one vinyl substituent.
[0205] 41. A method according to Embodiment 36 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned polysiloxane vinyl-based crosslinking agents comprise three or more phenylmethylsiloxane units.
[0206] 42. A method according to Embodiment 36 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned polysiloxane vinyl-based crosslinking agents comprise three or more diphenylsiloxane units.
[0207] 43. A method according to Example 36 or an ocular hydrogel contact lens, wherein the one or more polysiloxane vinyl-based crosslinking agents comprise one or more vinyl-terminated polyphenylmethylsiloxanes, one or more vinylphenylmethyl-terminated phenylmethyl-vinylphenylsiloxane copolymers, one or more vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymers, or a combination thereof.
[0208] 44. A method according to Example 36 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned polysiloxane vinyl-based crosslinking agents comprise one or more vinyl-terminated polyphenylmethylsiloxanes.
[0209] 45. A method according to Example 36 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned polysiloxane vinyl-based crosslinking agents comprise one or more vinylphenylmethyl-terminated phenylmethyl-vinylphenylsiloxane copolymers.
[0210] 46. A method according to any one of embodiments 16 to 45 or an ocular hydrogel contact lens, wherein the hydrophobic cross-linked acrylic material comprises a repeating unit of one or more aryl acrylic monomers of the following formula I or II:
[0211] [Chemical Formula I]
[0212]
[0213] [Chemical Formula II]
[0214]
[0215] In the formula, A1 is H or CH3 (preferably H); and B1 is (CH2) m1 or [O(CH2)2] Z1 (m1 is 2 to 6 and z1 is 1 to 10); Y1 is a direct bond, O, S or NR' (R' is H, CH3, C n' H 2n'+1 (n' is 1 to 10, iso-OC3H7, C6H5 or CH2C6H5) and; R a , R b , R c , R d , R e , R f , R g , R h and R i are independently H, C1-C 12 alkyl or C1-C 12 It is an alkoxy (preferably all H); where m1+w1≤8, w1 is 0 to 6; w2 is an integer from 1 to 3; and D1 is H, Cl, Br, C1-C4 alkyl, C1-C4 alkoxy, C6H5 or CH2C6H5.
[0216] 47. The above one or more aryl acrylate monomers are: 2-ethylphenoxyacrylate; 2-ethylphenoxymethacrylate; phenyl acrylate; phenyl methacrylate; benzyl acrylate; benzyl methacrylate; 2-phenylethyl acrylate; 2-phenylethyl methacrylate; 3-phenylpropyl acrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl acrylate; 4-phenylbutyl methacrylate; 4-methylphenyl acrylate; 4-methylphenyl methacrylate; 4-methylbenzyl acrylate; 4-methylbenzyl methacrylate; 2-(2-methylphenyl)ethyl acrylate; 2-(2-methylphenyl)ethyl methacrylate; 2-(3-methylphenyl)ethyl acrylate; 2-(3-methylphenyl)ethyl methacrylate; 2-(4-methylphenyl)ethyl acrylate; 2-(4-methylphenyl)ethyl methacrylate; 2-(4-propylphenyl)ethyl acrylate; 2-(4-propylphenyl)ethyl methacrylate; 2-(4-(1-methylethyl)phenyl)ethyl acrylate; 2-(4-(1-methylethyl)phenyl)ethyl methacrylate; 2-(4-methoxyphenyl)ethyl acrylate; 2-(4-methoxyphenyl)ethyl methacrylate; 2-(4-cyclohexylphenyl)ethyl acrylate; 2-(4-cyclohexylphenyl)ethyl methacrylate; 2-(2-chlorophenyl)ethyl acrylate; 2-(2-chlorophenyl)ethyl methacrylate; 2-(3-chlorophenyl)ethyl acrylate; 2-(3-chlorophenyl)ethyl methacrylate; 2-(4-chlorophenyl)ethyl acrylate; 2-(4-chlorophenyl)ethyl acrylate; 2-(4-bromophenyl)ethyl acrylate; 2-(4-bromophenyl)ethyl methacrylate; 2-(3-phenylphenyl)ethyl acrylate; 2-(3-phenylphenyl)ethyl methacrylate; 2-(4-phenylphenyl)ethyl acrylate; 2-(4-phenylphenyl)ethyl methacrylate; 2-(4-benzylphenyl)ethyl acrylate; 2-(4-benzylphenyl)ethyl methacrylate; 2-(phenylthio)ethyl acrylate; 2-(phenylthio)ethyl methacrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-benzyloxyethyl methacrylate;A method according to Embodiment 46 or an ocular hydrogel contact lens comprising one or more vinyl monomers selected from the group consisting of 3-benzyloxypropyl methacrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl methacrylate; and combinations thereof.;
[0217] 48. A method according to Embodiment 46 or an intraocular hydrogel contact lens, wherein the one or more aryl acrylate monomers comprises 2-phenylethyl acrylate; 3-phenylpropyl acrylate; 4-phenylbutyl acrylate; 5-phenylpentyl acrylate; 2-benzyloxyethyl acrylate; 3-benzyloxypropyl acrylate; 2-[2-(benzyloxy)ethoxy]ethyl acrylate; 2-phenylethyl methacrylate; 3-phenylpropyl methacrylate; 4-phenylbutyl methacrylate; 5-phenylpentyl methacrylate; 2-benzyloxyethyl methacrylate; 3-benzyloxypropyl methacrylate; 2-[2-(benzyloxy)ethoxy]ethyl methacrylate, or a combination thereof.
[0218] 49. A method according to any one of embodiments 16 to 48 or an ocular hydrogel contact lens, wherein the hydrophobic cross-linked acrylic material comprises repeating units of one or more hydrophobic vinyl monomers selected from the group consisting of vinyl alkanoate, vinyloxyalkane, styrene, vinyl toluene, vinyl chloride, vinylidene chloride, 1-butene, and combinations thereof.
[0219] 50. A method according to any one of embodiments 16 to 49 in which the hydrophobic insert is a rigid insert, or an ocular hydrogel contact lens.
[0220] 51. An ocular hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 50, wherein the bulk hydrogel material is a non-silicone hydrogel material comprising 50 mol% or more of repeating units of one or more hydroxyl-containing vinyl monomers.
[0221] 52. A method according to Embodiment 51 or an ocular hydrogel contact lens, wherein one or more of the above-mentioned hydroxyl-containing vinyl monomers are selected from the group consisting of hydroxyethyl (meth)acrylate, glycerol (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-amino-2-hydroxypropyl (meth)acrylate, N-2-hydroxyethyl (meth)acrylamide, N-3-hydroxypropyl (meth)acrylamide, N-2-hydroxypropyl (meth)acrylamide, N-2,3-dihydroxypropyl (meth)acrylamide, N-tris(hydroxymethyl)methyl (meth)acrylamide, vinyl alcohol, allyl alcohol, and combinations thereof.
[0222] 53. An ocular-implantable hydrogel contact lens according to any one of embodiments 1 to 3 and 5 to 50, wherein the bulk hydrogel material is a silicone hydrogel material.
[0223] 54. A bulk hydrogel material comprising (a) repeating units of one or more first polysiloxane vinyl-based crosslinking agents having one organic radical containing one or more H-bond donors and one methyl substituent in each unit, and (b) repeating units of one or more hydrophilic vinyl monomers, wherein the content of the one or more H-bond donors is about 0.8 meq / g or more based on the molecular weight of the one or more first polysiloxane vinyl-based crosslinking agents, a method according to Embodiment 53 or an ocular hydrogel contact lens.
[0224] 55. A method according to embodiment 54 or an ocular hydrogel contact lens, wherein the one or more first polysiloxane vinyl-based crosslinking agents have hydrophilic siloxane units each comprising one organic radical having one or more hydroxyl groups and one methyl substituent.
[0225] 56. A method according to Example 54 or 55 or an ocular hydrogel contact lens, wherein the content of one or more of the above-mentioned H-bond donors is about 1.0 meq / g or more based on the molecular weight of one or more of the above-mentioned first polysiloxane vinyl-based crosslinking agents.
[0226] 57. A method according to Example 54 or 55 or an ocular hydrogel contact lens, wherein the content of one or more of the above-mentioned H-bond donors is about 1.2 meq / g or more based on the molecular weight of one or more of the above-mentioned first polysiloxane vinyl-based crosslinking agents.
[0227] 58. A method according to Embodiment 54 or 55 or an ocular hydrogel contact lens, wherein the content of one or more of the above-mentioned H-bond donors is about 1.4 meq / g or more based on the molecular weight of one or more of the above-mentioned first polysiloxane vinyl-based crosslinking agents.
[0228] 59. The above one or more first polysiloxane vinyl-based crosslinking agents each comprise dimethylsiloxane units and one monovalent C4-C having 2 to 6 hydroxyl groups in each unit. 40 A method according to any one of embodiments 54 to 58 or an ocular hydrogel contact lens comprising a di-(meth)acryloyloxy-terminated polysiloxane vinyl-based crosslinking agent having hydrophilic siloxane units containing an organic radical substituent and one methyl substituent.
[0229] 60. A method according to any one of embodiments 54 to 58 or an ocular hydrogel contact lens, wherein one or more of the first polysiloxane vinyl-based crosslinking agents comprises a vinyl-based crosslinking agent of the following formula G:
[0230] [Chemical Formula G]
[0231]
[0232] In the equation,
[0233] d1 is an integer from 30 to 500 and d2 is an integer from 1 to 75, provided that d2 / d1 is approximately 0.035 to approximately 0.15;
[0234] X 01 is O or NR IN and, at this time R IN H or C1-C 10 - It is alkyl;
[0235] R I0 is H or methyl;
[0236] R I1 and R I2 C1-C that are independently substituted or unsubstituted 10 alkylene divalent radical or -R I4 -OR I5 - is a divalent radical, and in this case, R I4 and R I5 C1-C that are independently substituted or unsubstituted 10 It is an alkylene divalent radical;
[0237] R I3 is a monovalent radical of any one of the following chemical formulas G-1 to G-5:
[0238] [Chemical Formula G-1]
[0239]
[0240] [Chemical Formula G-2]
[0241]
[0242] [Chemical Formula G-3]
[0243]
[0244] [Chemical Formula G-4]
[0245]
[0246] [Chemical Formula G-5]
[0247]
[0248] In the equation,
[0249] k1 is 0 or 1; m1 is an integer from 2 to 4; m2 is an integer from 1 to 5; m3 is an integer from 3 to 6; m4 is an integer from 2 to 5; and
[0250] R I6 is H or methyl;
[0251] R I7 It is a C2-C6 hydrocarbon radical having an (m2+1) valence;
[0252] R I8 It is a C2-C6 hydrocarbon radical having an (m4+1) valence;
[0253] R I9 is ethyl or hydroxymethyl;
[0254] R I10 is methyl or hydromethyl;
[0255] R I11 is hydroxyl or methoxy;
[0256] X I1 The sulfur coupling of -S- or -NR I12 - is a tertiary amino group, where R I12 is a C1-C1 alkyl, hydroxyethyl, hydroxypropyl, or 2,3-dihydroxypropyl;
[0257] X I2 Is or It is an amide linkage of, and in this case, R I13 H or C1-C 10 It is an alkyl.
[0258] 61. A method according to Embodiment 60 or an ocular hydrogel contact lens, wherein d2 / d1 in formula G is about 0.040 to about 0.12.
[0259] 62. A method according to Embodiment 60 or an ocular hydrogel contact lens, wherein d2 / d1 in formula G is about 0.045 to about 0.10.
[0260] 63. In chemical formula G, R I3 A method according to any one of embodiments 60 to 62, wherein the radical is a monovalent radical of the chemical formula G-1, or an ocular-implantable hydrogel contact lens.
[0261] 64. In chemical formula G, R I3 A method according to any one of embodiments 60 to 62, wherein the radical is a monovalent radical of chemical formula G-2, or an ocular-implantable hydrogel contact lens.
[0262] 65. In chemical formula G, R I3 A method according to any one of embodiments 60 to 62, wherein the radical is a monovalent radical of chemical formula G-3, or an ocular-implantable hydrogel contact lens.
[0263] 66. In chemical formula G, R I3 A method according to any one of embodiments 60 to 62, wherein the radical is a monovalent radical of the chemical formula G-4, or an ocular-implantable hydrogel contact lens.
[0264] 67. In chemical formula G, R I3 A method according to any one of embodiments 60 to 62, wherein the radical is a monovalent radical of the chemical formula G-5, or an ocular-implantable hydrogel contact lens.
[0265] 68. The above one or more hydrophilic vinyl monomers are: (1) alkyl (meth)acrylamide selected from the group consisting of (meth)acrylamide, N,N-dimethyl (meth)acrylamide, N-ethyl (meth)acrylamide, N,N-diethyl (meth)acrylamide, N-propyl (meth)acrylamide, N-isopropyl (meth)acrylamide, N-3-methoxypropyl (meth)acrylamide, and combinations thereof; (2) N-2-hydroxyethyl (meth)acrylamide, N,N-bis(hydroxyethyl)(meth)acrylamide, N-3-hydroxypropyl (meth)acrylamide, N-2-hydroxypropyl (meth)acrylamide, N-2,3-dihydroxypropyl (meth)acrylamide, N-tris(hydroxymethyl)methyl (meth)acrylamide, 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, glycerol methacrylate (GMA), di(ethylene glycol)(meth)acrylate, tri(ethylene glycol)(meth)acrylate, tetra(ethylene glycol)(meth)acrylate, poly(ethylene glycol)(meth)acrylate with a number average molecular weight of 1500 or less, and poly(ethylene glycol)(meth)acrylate with a number average molecular weight of 1500 or less A hydroxyl-containing acrylic monomer selected from the group consisting of poly(ethylene glycol)ethyl (meth)acrylamide and combinations thereof; (3) A carboxyl-containing acrylic monomer selected from the group consisting of 2-(meth)acrylamidoglycolic acid, (meth)acrylic acid, ethylacrylic acid, 3-(meth)acrylamidopropionic acid, 5-(meth)acrylamidopentanoic acid, 4-(meth)acrylamidobutanoic acid, 3-(meth)acrylamido-2-methylbutanoic acid, 3-(meth)acrylamido-3-methylbutanoic acid, 2-(meth)acrylamido-2-methyl-3,3-dimethylbutanoic acid, 3-(meth)acrylamidohexanoic acid, 4-(meth)acrylamido-3,3-dimethylhexanoic acid, and combinations thereof;(4) N-2-aminoethyl (meth)acrylamide, N-2-methylaminoethyl (meth)acrylamide, N-2-ethylaminoethyl (meth)acrylamide, N-2-dimethylaminoethyl (meth)acrylamide, N-3-aminopropyl (meth)acrylamide, N-3-methylaminopropyl (meth)acrylamide, N-3-dimethylaminopropyl (meth)acrylamide, 2-aminoethyl (meth)acrylate, 2-methylaminoethyl (meth)acrylate, 2-ethylaminoethyl (meth)acrylate, 3-aminopropyl (meth)acrylate, 3-methylaminopropyl (meth)acrylate, 3-ethylaminopropyl (meth)acrylate, 3-amino-2-hydroxypropyl (meth)acrylate, trimethylammonium 2-hydroxypropyl (meth)acrylate hydrochloride, dimethylaminoethyl (meth)acrylate, Amino-containing acrylic monomers selected from the group consisting of combinations thereof;(5) N-vinylpyrrolidone (also known as N-vinyl-2-pyrrolidone), N-vinyl-3-methyl-2-pyrrolidone, N-vinyl-4-methyl-2-pyrrolidone, N-vinyl-5-methyl-2-pyrrolidone, N-vinyl-6-methyl-2-pyrrolidone, N-vinyl-3-ethyl-2-pyrrolidone, N-vinyl-4,5-dimethyl-2-pyrrolidone, N-vinyl-5,5-dimethyl-2-pyrrolidone, N-vinyl-3,3,5-trimethyl-2-pyrrolidone, N-vinylpiperidone (also known as N-vinyl-2-piperidone), N-vinyl-3-methyl-2-piperidone, N-vinyl-4-methyl-2-piperidone, N-vinyl-5-methyl-2-piperidone, N-vinyl-6-methyl-2-piperidone, N-vinyl-6-ethyl-2-piperidone, N-vinyl-3,5-dimethyl-2-piperidone, N-vinyl-4,4-dimethyl-2-piperidone, N-vinyl caprolactam (also known as N-vinyl-2-caprolactam), N-vinyl-3-methyl-2-caprolactam, N-vinyl-4-methyl-2-caprolactam, N-vinyl-7-methyl-2-caprolactam, N-vinyl-7-ethyl-2-caprolactam, N-vinyl-3,5-dimethyl-2-caprolactam, N-vinyl-4,6-dimethyl-2-caprolactam, N-vinyl-3,5,7-trimethyl-2-caprolactam, N-vinyl-N-methylacetamide, N-vinyl formamide, N-vinyl acetamide, N-vinyl amide monomer selected from the group consisting of N-vinyl isopropylamide, N-vinyl-N-ethyl acetamide, N-vinyl-N-ethyl formamide, and mixtures thereof; (6) A methylene-containing pyrrolidone monomer selected from the group consisting of 1-methyl-3-methylene-2-pyrrolidone, 1-ethyl-3-methylene-2-pyrrolidone, 1-methyl-5-methylene-2-pyrrolidone, 1-ethyl-5-methylene-2-pyrrolidone, 5-methyl-3-methylene-2-pyrrolidone, 5-ethyl-3-methylene-2-pyrrolidone, 1-n-propyl-3-methylene-2-pyrrolidone, 1-n-propyl-5-methylene-2-pyrrolidone, 1-isopropyl-3-methylene-2-pyrrolidone, 1-isopropyl-5-methylene-2-pyrrolidone, 1-n-butyl-3-methylene-2-pyrrolidone, 1-tert-butyl-3-methylene-2-pyrrolidone, and combinations thereof;(7) An acrylic monomer having a C1-C4 alkoxyethoxy group, selected from the group consisting of ethylene glycol methyl ether (meth)acrylate, di(ethylene glycol) methyl ether (meth)acrylate, tri(ethylene glycol) methyl ether (meth)acrylate, tetra(ethylene glycol) methyl ether (meth)acrylate, C1-C4-alkoxy poly(ethylene glycol) (meth)acrylate having a number average molecular weight of 1500 or less, methoxy-poly(ethylene glycol)ethyl (meth)acrylamide having a number average molecular weight of 1500 or less, and combinations thereof; (8) A vinyl ether monomer selected from the group consisting of ethylene glycol monovinyl ether, di(ethylene glycol) monovinyl ether, tri(ethylene glycol) monovinyl ether, tetra(ethylene glycol) monovinyl ether, poly(ethylene glycol) monovinyl ether, ethylene glycol methyl vinyl ether, di(ethylene glycol) methyl vinyl ether, tri(ethylene glycol) methyl vinyl ether, tetra(ethylene glycol) methyl vinyl ether, poly(ethylene glycol) methyl vinyl ether, and combinations thereof; (9) an allyl ether monomer selected from the group consisting of ethylene glycol monoallyl ether, di(ethylene glycol) monoallyl ether, tri(ethylene glycol) monoallyl ether, tetra(ethylene glycol) monoallyl ether, poly(ethylene glycol) monoallyl ether, ethylene glycol methylallyl ether, di(ethylene glycol) methylallyl ether, tri(ethylene glycol) methylallyl ether, tetra(ethylene glycol) methylallyl ether, poly(ethylene glycol) methylallyl ether, and combinations thereof;(10) (meth)acryloyloxyethyl phosphorylcholine, (meth)acryloyloxypropyl phosphorylcholine, 4-((meth)acryloyloxy)butyl-2'-(trimethylammonio)ethyl phosphate, 2-[(meth)acryloylamino]ethyl-2'-(trimethylammonio)-ethyl phosphate, 3-[(meth)acryloylamino]propyl-2'-(trimethylammonio)ethyl phosphate, 4-[(meth)acryloylamino]butyl-2'-(trimethylammonio)ethyl phosphate, 5-((meth)acryloyloxy)-pentyl-2'-(trimethylammonio)ethyl phosphate, 6-((meth)acryloyloxy)hexyl-2'-(trimethylammonio)ethyl phosphate, 2-((meth)acryloyloxy)ethyl-2'-(triethylammonio)-ethyl phosphate, 2-((meth)acryloyloxy)ethyl-2'-(tripropylammonio)ethyl phosphate, 2-((meth)acryloyloxy)ethyl-2'-(tributylammonio)ethyl phosphate, 2-((meth)acryloyloxy)propyl-2'-(trimethylammonio)-ethyl phosphate, 2-((meth)acryloyloxy)butyl-2'-(trimethylammonio)-ethyl phosphate, 2-((meth)acryloyloxy)pentyl-2'-(trimethylammonio)ethyl phosphate, 2-((meth)acryloyloxy)hexyl-2'-(trimethylammonio)ethyl phosphate, A phosphorylcholine-containing vinyl monomer selected from the group consisting of 2-(vinyloxy)ethyl-2'-(trimethylammonio)ethyl phosphate, 2-(allyloxy)ethyl-2'-(trimethylammonio)ethyl phosphate, 2-(vinyloxycarbonyl)ethyl-2'-(trimethylammonio)ethyl phosphate, 2-(allyloxycarbonyl)ethyl-2'-(trimethylammonio)-ethyl phosphate, 2-(vinylcarbonylamino)ethyl-2'-(trimethylammonio)ethyl phosphate, 2-(allyloxycarbonylamino)ethyl-2'-(trimethylammonio)ethyl phosphate, 2-(butenoyloxy)ethyl-2'-(trimethylammonio)ethyl phosphate, and combinations thereof; (11) allyl alcohol; (12) N-2-hydroxyethyl vinyl carbamate; (13) N-carboxyvinyl-β-alanine (VINAL); (14) N-carboxyvinyl-α-alanine;(15) A method according to any one of embodiments 54 to 67 comprising (15) or a combination thereof, or an ocular silicone hydrogel contact lens.;
[0266] 69. A method according to any one of embodiments 54 to 67 or an ocular hydrogel contact lens, wherein one or more of the above hydrophilic vinyl monomers comprise N-vinylpyrrolidone, N-vinyl-N-methylacetamide, or a combination thereof.
[0267] 70. A method according to any one of embodiments 54 to 69 or an ocular silicone hydrogel contact lens, wherein one or more of the above hydrophilic vinyl monomers comprise N,N-dimethyl (meth)acrylamide.
[0268] 71. One or more of the above hydrophilic vinyl monomers are N-2-hydroxyethyl (meth)acrylamide, N,N-bis(hydroxyethyl)(meth)acrylamide, N-3-hydroxypropyl (meth)acrylamide, N-2-hydroxypropyl (meth)acrylamide, N-2,3-dihydroxypropyl (meth)acrylamide, N-tris(hydroxymethyl)methyl (meth)acrylamide, 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, glycerol methacrylate (GMA), di(ethylene glycol)(meth)acrylate, tri(ethylene glycol)(meth)acrylate, tetra(ethylene glycol)(meth)acrylate, poly(ethylene glycol)(meth)acrylate having a number average molecular weight of 1500 or less, A method according to any one of embodiments 54 to 70 or an ocular hydrogel contact lens comprising poly(ethylene glycol)ethyl (meth)acrylamide having a number average molecular weight of 1500 or less, or a combination thereof.
[0269] 72. A method according to any one of embodiments 54 to 71 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises a repeating unit of one or more silicone-containing vinyl monomers selected from the group consisting of a vinyl monomer having a bis(trialkylsilyloxy)alkylsilyl group, a vinyl monomer having a tris(trialkylsilyloxy)silyl group, a polysiloxane vinyl monomer, 3-methacryloxypropylpentamethyldisiloxane, t-butyldimethylsiloxyethyl vinyl carbonate, trimethylsilylethyl vinyl carbonate, trimethylsilylmethyl vinyl carbonate, and combinations thereof.
[0270] 73. A method according to any one of embodiments 54 to 71 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises repeating units of one or more silicone-containing vinyl monomers of the following formula M1 or M2:
[0271] [Chemical Formula M1]
[0272]
[0273] [Chemical Formula M2]
[0274]
[0275] In the equation,
[0276] a M1 is 0 or 1 and; R M0 is H or methyl; X M0 is O or NR M1 Igo; L M1 C2-C8 alkylene divalent radical or , , , , , , or The divalent radical of; L M1' is a C2-C8 alkylene divalent radical having 0 or 1 hydroxyl group; L M1" is a C3-C8 alkylene divalent radical having 0 or 1 hydroxyl group; XM1 은 O, NR M1 , NHCOO, OCONH, CONR M1 , or NR M1 CO and; R M1 is H, or a C1-C4 alkyl having 0 or 2 hydroxyl groups; R t1 and R t2 are independently C1-C6 alkyls; X M1' is O or NR1; v1 is an integer from 1 to 30; m2 is an integer from 0 to 30; n1 is an integer from 3 to 40; and r1 is an integer from 2 or 3.
[0277] 74. The silicone hydrogel material is tris(trimethylsilyloxy)silylpropyl (meth)acrylate, [3-(meth)acryloxy-2-hydroxypropyloxy]propylbis(trimethylsiloxy)methylsilane, [3-(meth)acryloxy-2-hydroxypropyloxy]propylbis(trimethylsiloxy)butylsilane, 3-(meth)acryloxy-2-(2-hydroxyethoxy)-propyloxy)propylbis(trimethylsiloxy)methylsilane, 3-(meth)acryloxy-2-hydroxypropyloxy)propyltris(trimethylsiloxy)silane, N-[tris(trimethylsiloxy)silylpropyl]-(meth)acrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)propyl)-2-methyl(meth)acrylamide, N-(2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)-propyl) (meth)acrylamide, N-(2-hydroxy-3-(3-(tris)(trimethylsilyloxy)silyl)propyloxy)propyl)-2-methylacrylamide, N-(2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)propyl) (meth)acrylamide, N-[tris(dimethylpropylsiloxy)silylpropyl]-(meth)acrylamide, N-[tris(dimethylphenylsiloxy)-silylpropyl](meth)acrylamide, N-[tris(dimethylethylsiloxy)-silylpropyl](meth)acrylamide, N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)-propyloxy)propyl]-2-methyl (Met)acrylamide, N,N-bis[2-hydroxy-3-(3-(bis(trimethylsilyloxy)methylsilyl)propyloxy)-propyl] (Met)acrylamide, N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)propyloxy)-propyl]-2-methyl (Met)acrylamide, N,N-bis[2-hydroxy-3-(3-(tris(trimethylsilyloxy)silyl)-propyloxy)propyl] (Met)acrylamide, N-[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)-propyl]-2-methyl (Met)acrylamide, N-[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)-propyl] (Met)acrylamide, N,A method according to any one of Embodiments 54 to 71 or an intraocular hydrogel contact lens, wherein N-bis[2-hydroxy-3-(3-(t-butyldimethylsilyl)propyloxy)propyl]-2-methyl(meth)acrylamide, N-2-(meth)acryloxyethyl-O-(methyl-bis-trimethylsiloxy-3-propyl)silyl carbamate, 3-(trimethylsilyl)propylvinyl carbonate, 3-(vinyloxycarbonylthio)-propyl-tris(trimethyl-siloxy)silane, 3-[tris(trimethylsiloxy)silyl]propylvinyl carbamate, 3-[tris(trimethylsiloxy)silyl]propyl allyl carbamate, 3-[tris(trimethylsiloxy)silyl]propyl vinyl carbonate, or a combination thereof.
[0278] 75. The silicone hydrogel material is α-(meth)acryloxypropyl terminal ω-C1-C4-alkyl terminal polydimethylsiloxane, α-(meth)acryloxy-2-hydroxypropyloxypropyl terminal ω-C1-C4-alkyl terminal polydimethylsiloxane, α-(2-hydroxyl-methacryloxypropyloxypropyl)-ω-C1-C4-alkyl-decamethylpentasiloxane, α-[3-(meth)acryloxyethoxy-2-hydroxypropyloxypropyl]-terminal ω-C1-C4-alkyl terminal polydimethylsiloxane, α-[3-(meth)acryloxy-propyloxy-2-hydroxypropyloxypropyl]-terminal ω-C1-C4-alkyl terminal polydimethylsiloxane, α-[3-(meth)acryloxyisopropyloxy-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acryloxybutyloxy-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acryloxyethylamino-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acryloxypropylamino-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acryloxy-butylamino-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[(meth)acryloxy(polyethyleneoxy)-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[(meth)acryloxy-2-hydroxypropyloxy-ethoxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[(meth)acryloxy-2-hydroxypropyl-N-ethylaminopropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[(meth)acryloxy-2-hydroxypropyl-aminopropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[(meth)acryloxy-2-hydroxypropyloxy-(polyethyleneoxy)propyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-(meth)acryloylamidopropyloxypropyl terminal ω-C1-C4-alkyl terminal polydimethylsiloxane,α-N-methyl-(meth)acryloylamidopropyloxypropyl terminal ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acrylamidoethoxy-2-hydroxypropyloxy-propyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acrylamidopropyloxy-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acrylamidoisopropyloxy-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acrylamidobutyloxy-2-hydroxypropyloxypropyl]-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-(meth)acryloylamido-2-hydroxypropyloxypropyl] terminal ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-[3-[N-methyl-(meth)acryloylamido]-2-hydroxypropyloxypropyl] terminal ω-C1-C4-alkyl polydimethylsiloxane, N-methyl-N'-(propyltetra(dimethylsiloxy)dimethylbutylsilane) (meth)acrylamide, N-(2,3-dihydroxypropane)-N'-(propyltetra(dimethylsiloxy)dimethylbutylsilane) (meth)acrylamide, (meth)acryloylamidopropyltetra(dimethylsiloxy)dimethylbutylsilane, α-vinyl carbonate-terminated ω-C1-C4-alkyl-terminated polydimethylsiloxane, α-vinyl carbamate-terminated A method according to any one of embodiments 54 to 74 or an ocular hydrogel contact lens comprising ω-C1-C4-alkyl-terminated polydimethylsiloxane or a mixture thereof.
[0279] 76. A method according to any one of embodiments 54 to 75 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises a repeating unit of one or more second polysiloxane vinyl-based crosslinking agents.
[0280] 77. A method according to Embodiment 76 or an ocular hydrogel contact lens, wherein one or more of the second polysiloxane vinyl-based crosslinking agents comprise di-(meth)acryloyl-terminated polydimethylsiloxane; di-vinyl carbonate-terminated polydimethylsiloxane; di-vinyl carbamate-terminated polydimethylsiloxane; N,N,N',N'-tetrakis(3-methacryloxy-2-hydroxypropyl)-α,ω-bis-3-aminopropyl-polydimethylsiloxane; or a combination thereof.
[0281] 78. A method according to embodiment 76 or an ocular hydrogel contact lens, wherein the one or more second polysiloxane vinyl crosslinking agents comprise: (1) a vinyl crosslinking agent having two terminal ethylenically unsaturated groups selected from the group consisting of (meth)acryloyloxy groups, (meth)acryloylamino groups, vinyl carbonate groups, and vinyl carbamate groups, and a single polydiorganosiloxane segment; and / or (2) a chain-extended polysiloxane vinyl crosslinking agent having two terminal ethylenically unsaturated groups selected from the group consisting of (meth)acryloyloxy groups, (meth)acryloylamino groups, vinyl carbonate groups, and vinyl carbamate groups, two or more polydiorganosiloxane segments, and covalent bonding groups between each pair of polydiorganosiloxane segments.
[0282] 79. The above one or more second polysiloxane vinyl-based crosslinking agents are α,ω-bis[3-(meth)acrylamidopropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acryloxypropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acryloxy-2-hydroxypropyloxypropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acryloxyethoxy-2-hydroxypropyloxypropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acryloxypropyloxy-2-hydroxypropyloxypropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acryloxy-isopropyloxy-2-hydroxypropyloxypropyl]-terminated polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidoethoxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidoethoxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidopropyloxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidoisopropyloxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidobutyloxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidobutyloxy-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidoethylamino-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acryloxypropylamino-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acryloxybutylamino-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[(meth)acrylamidoethylamino-2-hydroxypropyloxy-propyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamidopropylamino-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[3-(meth)acrylamide-butylamino-2-hydroxypropyloxypropyl]-terminal polydimethylsiloxane, α,ω-bis[(meth)acryloxy-2-hydroxypropyloxy-ethoxypropyl]-terminal polydimethylsiloxane, α,A method according to Embodiment 76 or an intraocular hydrogel contact lens comprising ω-bis[(meth)acryloxy-2-hydroxypropyl-N-ethylaminopropyl]-terminated polydimethylsiloxane, α,ω-bis[(meth)acryloxy-2-hydroxypropyl-aminopropyl]-polydimethylsiloxane, α,ω-bis[(meth)acryloxy-2-hydroxypropyloxy-(polyethyleneoxy)propyl]-terminated polydimethylsiloxane, α,ω-bis[(meth)acryloxyethylamino-carbonyloxy-ethoxypropyl]-terminated polydimethylsiloxane, α,ω-bis[(meth)acryloxyethylamino-carbonyloxy-(polyethyleneoxy)propyl]-terminated polydimethylsiloxane, or a combination thereof.
[0283] 80. A method according to any one of embodiments 54 to 79 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises repeating units of one or more non-silicone vinyl-based crosslinking agents.
[0284] 81. One or more of the above-mentioned non-silicon vinyl crosslinking agents are ethylene glycol di-(meth)acrylate, diethylene glycol di-(meth)acrylate, triethylene glycol di-(meth)acrylate, tetraethylene glycol di(meth)acrylate, glycerol di(meth)acrylate, 1,3-propanediol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,4-butanediol di(meth)acrylate, glycerol 1,3-diglycerolate di-(meth)acrylate, ethylenebis[oxy(2-hydroxypropane-1,3-diyl)] di-(meth)acrylate, bis[2-(meth)acryloxyethyl]phosphate, trimethylolpropane di-(meth)acrylate, 3,4-Bis[(meth)acryloyl]tetrahydrofuane, diacrylamide, dimethacrylamide, N,N-di(meth)acryloyl-N-methylamine, N,N-di(meth)acryloyl-N-ethylamine, N,N'-methylenebis(meth)acrylamide, N,N'-ethylenebis(meth)acrylamide, N,N'-dihydroxyethylenebis(meth)acrylamide, N,N'-propylenebis(meth)acrylamide, N,N'-2-hydroxypropylenebis(meth)acrylamide, N,N'-2,3-dihydroxybutylenebis(meth)acrylamide, 1,3-bis(meth)acrylamidepropane-2-yl phosphate dihydrogen, piperazine diacrylamide, tetraethyleneglycol divinyl ether, triethyleneglycol divinyl ether, diethyleneglycol divinyl A method according to Embodiment 80 or an ocular hydrogel contact lens comprising ether, ethylene glycol divinyl ether, trialyl isocyanurate, trialyl cyanurate, trimethylopropane trimethacrylate, pentaerythritol tetramethacrylate, bisphenol A dimethacrylate, allyl methacrylate, allyl acrylate, N-allyl-methacrylamide, N-allyl-acrylamide, or a combination thereof.
[0285] 82. A method according to any one of embodiments 54 to 81 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises repeating units of one or more blended vinyl monomers.
[0286] 83. The above-mentioned one or more blended vinyl monomers are, C1-C 10 A method according to Embodiment 82 or an ocular hydrogel contact lens comprising alkyl (meth)acrylate, cyclopentyl acrylate, cyclohexyl methacrylate, cyclohexyl acrylate, isobornyl (meth)acrylate, styrene, 4,6-trimethylstyrene (TMS), t-butyl styrene (TBS), trifluoroethyl (meth)acrylate, hexafluoro-isopropyl (meth)acrylate, hexafluorobutyl (meth)acrylate, or a combination thereof.
[0287] 84. A method according to any one of embodiments 54 to 83 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises repeating units of one or more polymer materials selected from the group consisting of UV-absorbing vinyl monomers, UV / HEVL-absorbing vinyl monomers, photochromic vinyl monomers, polymerizable dyes, and combinations thereof.
[0288] 85. A method according to any one of embodiments 54 to 84 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises about 5 weight percent or more of a first polysiloxane vinyl-based crosslinking agent.
[0289] 86. A method according to any one of embodiments 54 to 84 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises about 10 weight% or more of a first polysiloxane vinyl-based crosslinking agent.
[0290] 87. A method according to any one of embodiments 54 to 84 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises about 15 weight% or more of a first polysiloxane vinyl-based crosslinking agent.
[0291] 88. A method according to any one of embodiments 54 to 84 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises about 20 weight% or more of a first polysiloxane vinyl-based crosslinking agent.
[0292] 89. A method according to any one of embodiments 54 to 84 or an ocular hydrogel contact lens, wherein the silicone hydrogel material comprises about 25 weight% or more of a first polysiloxane vinyl-based crosslinking agent.
[0293] 90. A method according to any one of embodiments 54 to 89 or an ocular hydrogel contact lens, wherein the silicone hydrogel material has an equilibrium water content (i.e., water content when fully hydrated or being fully hydrated) of about 20% by weight to about 70% by weight, an oxygen permeability of about 40% or more, and an elastic modulus (i.e., Young's modulus) of about 1.5 MPa or less.
[0294] 91. A silicone hydrogel material having an equilibrium water content (i.e., water content when fully hydrated or being fully hydrated) of about 20% by weight to about 65% by weight, a method according to any one of embodiments 54 to 89 or an ocular hydrogel contact lens.
[0295] 92. A silicone hydrogel material having an equilibrium water content (i.e., water content when fully hydrated or being fully hydrated) of about 25% by weight to about 65% by weight, a method according to any one of embodiments 54 to 89 or an ocular hydrogel contact lens.
[0296] 93. A silicone hydrogel material having an equilibrium water content (i.e., water content when fully hydrated or being fully hydrated) of about 30% by weight to about 60% by weight, a method according to any one of embodiments 54 to 89 or an ocular hydrogel contact lens.
[0297] 94. A silicone hydrogel material having an oxygen permeability of about 60 times or more (preferably about 80 times to about 160 times) a method according to any one of embodiments 54 to 93 or an ocular hydrogel contact lens.
[0298] 95. A silicone hydrogel material having an elastic modulus (i.e., Young's modulus) of about 0.2 MPa to about 1.2 MPa, a method according to any one of embodiments 54 to 94 or an ocular hydrogel contact lens.
[0299] 96. A silicone hydrogel material having an elastic modulus (i.e., Young's modulus) of about 0.3 MPa to about 1.1 MPa, a method according to any one of embodiments 54 to 96 or an ocular hydrogel contact lens.
[0300] Based on the foregoing disclosure, those skilled in the art will be able to practice the present invention. Various modifications, variations, and combinations of the various embodiments described herein may be made. Readers of this document are encouraged to refer to the following examples to better understand specific embodiments and their advantages. This specification and the examples are intended to be regarded as illustrative.
[0301] Example 1
[0302] Oxygen permeability measurement
[0303] Unless specifically stated otherwise, the oxygen permeability (Dk / t) and intrinsic (or edge-corrected) oxygen permeability (Dk) of the implant and implant material according to the procedures set forth in ISO 18369-4 i or Dk c Measures ).
[0304] Equilibrium moisture content
[0305] The equilibrium water content (EWC) of a contact lens is calculated as follows.
[0306] Measure the amount of water (expressed in weight percent) present in a hydrated hydrogel contact lens that is fully equilibrated in saline solution at room temperature. Quickly stack the lenses, wipe them with a cloth, and then transfer the lens stack to an aluminum pan on an analytical balance. Typically, five lenses are placed in each sample pan. Record the combined weight of the hydrated lenses and the pan. Cover the pan with aluminum foil. Place the pan in a laboratory oven at 100 ± 2°C and dry it for 16 to 18 hours. Remove the pan and lenses from the oven and cool them in a desiccator for at least 30 minutes. Remove one pan from the desiccator and discard the aluminum foil. Weigh the corresponding pan and the dried lens sample together on the analytical balance. Repeat this process for all pans. By subtracting the weight of the empty pan, the wet and dry weights of the lens samples can be calculated.
[0307] Refractive index
[0308] The refractive index (RI) of the insert is measured at 25°C using a Reichert Abbe Mark III refractometer from the Abbe transmission laboratory. Prior to the measurement, the insert is fully equilibrated in a PBS solution.
[0309] Elastic modulus
[0310] The storage modulus (Young's modulus) of the insert is measured using a TA RSA-G2 DMA (Dynamic Mechanical Analyzer). The insert is cut into a 3.08 mm wide strip using a Precision Concept dry lens cutter. Five thickness values are measured within a 6.5 mm gauge length. The strip is mounted on the instrument using the metal grips of the Dynamic Mechanical Analyzer. The vibration temperature rise rate of the insert is tested at a linear rate of 2°C / min from 10°C to 50°C, and the material's response to temperature increase is monitored at a constant frequency of 1 Hz, a constant amplitude of 0.5% strain, and a sampling rate of 10.0 pts / s. The storage modulus (E'), loss modulus (E''), and tan δ data are calculated using TRIOS software.
[0311] The elastic modulus of a silicone hydrogel material or contact lens is measured using the MTS Insight instrument. The contact lens is first cut into a 3.12 mm wide strip using a Precision Concept 2 stage cutter. Five thickness values are measured within a 6.5 mm gauge length. The strip is mounted on the instrument grips and immersed in PBS (phosphate-buffered saline) temperature-controlled to 21 ± 2°C. Typically, a 5 N load cell is used for this test. A constant force and speed are applied to the sample until it fractures. Force and displacement data are collected using TestWorks software. Using TestWorks software, the elastic modulus value is calculated as the slope or tangent of the stress-strain curve at the point where the elongation is close to zero in the elastic deformation region.
[0312] glass transition temperature
[0313] Glass transition temperature (T of the insert) g ) is defined as the peak of tan δ in the aforementioned dynamic temperature rise rate test.
[0314] Delayering
[0315] The possibility of delamination of the intraocular hydrogel contact lens is examined using an Optimec device or OCT (Optical Coherence Tomography).
[0316] Regardless of the evaluation method, prior to the delamination study, the contact lens is processed by running it in an autoclave and then left at room temperature for at least 12 hours (staged).
[0317] After satisfying the required staging time, place the fully hydrated contact lens into the "V" counter line assembly of the Optimec instrument (OPTIMEC, UK, Model JCF). Once the contact lens is seated under the influence of gravity, carefully inspect the front surface of the contact lens for any traces of a circular pattern. In the Optimec image, delamination appears as a circular pattern.
[0318] Additionally, delamination can be studied using OCT (Spectral Domain Optical Coherence Tomography, model Telesto-II; Thorlabs). OCT enables non-invasive imaging of contact lenses, allowing for the acquisition of high-resolution cross-sectional images. To do this, after meeting minimum staging requirements, the contact lens is removed from the blister and immersed in PBS solution for at least 30 minutes to reach equilibrium. Then, a "V" block-shaped cuvette is filled with fresh PBS solution to approximately ¾ full, and the contact lens is transferred into the cuvette using a Q-tip. The entire contact lens is scanned at 10-degree intervals while allowing the lens to float freely in the "V" shape at the bottom of the cuvette. In the OCT images, delamination is identified as air pockets forming at the intermediate interface between the insert and the carrier.
[0319] chemical
[0320] The following abbreviations are used in the embodiments described below: PETA represents pentaerythritol tetraacrylate; TrisMA represents 3-[tris(trimethylsiloxy)silyl]propyl methacrylate; HFIPMA represents hexafluoroisopropyl methacrylate; NPGDMA represents neopentyl glycol dimethacrylate; DMA represents N,N-dimethylacrylamide; HEMA represents 2-hydroxyethyl methacrylate; TEGDMA represents triethylene glycol dimethacrylate; VAZO-52 represents 2-2'-azobis(2,4-dimethylvaleronitrile); VAZO-67 represents 2,2'-azobis(2-methylbutyronitrile); RB247 is Reactive Blue 247; and EGBE represents ethylene glycol butyl ether; PBS represents a phosphate-buffered saline solution having a pH of 7.2 ± 0.2 at 25°C and containing about 0.044 wt% NaH2PO4·H2O, about 0.388 wt% Na2HPO4·2H2O, and about 0.79 wt% NaCl; wt% represents a weight percentage; Betacon represents a dimethacrylate-terminated chain-extended polydimethylsiloxane (number average molecular weight about 5000 g / mol) prepared according to a method similar to that described in Example B-1 of U.S. Patent No. 5,760,100 (the whole incorporated herein by reference) (a structure in which two PDMS segments are separated from each other by a perfluoropolyether (PFPE), a diurethane linker connects the PDMS segment and the PFPE segment, and each of the two urethane linkers is located between one terminal methacrylate group and one PDMS segment to connect the two); PrOH represents 1-propanol; and the "H4" macromonomer represents a di-methacryloyloxypropyl-terminated polysiloxane of the following formula A (number average molecular weight of about 11.3K to 12.3K g / mol and OH content of about 1.82 to 2.01 meq / g):
[0321] [Chemical Formula A]
[0322] .
[0323] Example 2
[0324] Composition for forming inserts
[0325] The following components (materials) are all combined in air at room temperature to prepare a base insert-forming composition (i.e., an insert formulation) for producing a hard hydrophobic insert: 45 parts by weight of HFIPMA; 21 parts by weight of NPGDMA; 45 parts by weight of TrisMA; 0.5 parts by weight of PETA; 3 parts by weight of RB247; and 0.5 parts by weight of Vazo-67. Then, 1 wt%, 0.1 wt%, and 0.02 wt% of magnetite (Sensient Cosmetics, black iron oxide, 2 to 5 μm) are added to prepare three magnetization compositions for insert formation. Black iron oxide (II, III) may also be incorporated by first forming a suspension containing TRIS-MA or other monofunctional monomers that are part of the insert formulation. The above suspension is generally 5 to 50% black iron oxide (w / w) and is formed by a ball milling method.
[0326] Lens-forming composition
[0327] A lens-forming composition (i.e., SiHy lens formulation) is prepared by combining all of the following components (substances) in air at room temperature: 33 parts by weight of H4; 17 parts by weight of TrisMA; 24 parts by weight of DMA; 1 part by weight of TEGDMA; 25.5 parts by weight of EGBE; and 0.5 parts by weight of Vazo-67.
[0328] Manufacture of ocular implantable silicone hydrogel contact lenses
[0329] The insert-forming composition prepared as described above is purged with nitrogen at room temperature for 30 to 35 minutes. A predetermined amount of the nitrogen-purged insert-forming composition is placed in the center of the molding surface of a female half-mold made of polypropylene. The female half-lens mold containing the insert-forming composition is closed with a male half-mold made of polypropylene and placed in an oven. The oven is configured as follows: a nitrogen supply device is connected to the oven via a high-flow capacity controller capable of controlling the flow rate of nitrogen passing through the oven, and vacuum pumps are connected to the oven's exhaust line to control the differential pressure of the oven.
[0330] The composition for forming an insert inside a mold is heat-cured in an oven under the following conditions: raised from room temperature to 55°C at a rate of about 7°C / min; maintained at 55°C for about 30 to 40 minutes; raised from 55°C to 80°C at a rate of about 7°C / min; maintained at 55°C for about 30 to 40 minutes; raised from 80°C to 100°C at a rate of about 7°C / min; and maintained at 100°C for about 30 to 40 minutes. The mold is opened, and the molded insert is separated from the half-mold to which the insert is attached.
[0331] As a control, a non-magnetized implant is obtained from a base implant-forming formulation (containing no magnetite).
[0332] A magnetized or non-magnetic insert manufactured as described above is placed in the central area of the molding surface of a female half-mold (made of polypropylene), and a predetermined amount of the SiHy lens formulation manufactured as described above is dosed into the female half-mold so that the magnetized insert is immersed, and then a male half-mold made of polypropylene is placed on top of the female half-mold and the mold is tightly closed. By placing a magnet (rare earth, SmCo, applied field 50 to 2000 Gauss) under the female half-mold, the magnetized insert is positioned in the center and maintained or fixed in its proper position within the closed mold.
[0333] A closed mold containing a magnetized insert immersed in a SiHy lens formulation is heat-cured in an oven under the following conditions: raised from room temperature to 55°C at a rate of about 7°C / min; maintained at 55°C for about 30 to 40 minutes; raised from 55°C to 80°C at a rate of about 7°C / min; maintained at 55°C for about 30 to 40 minutes; raised from 80°C to 100°C at a rate of about 7°C / min; and maintained at 100°C for about 30 to 40 minutes. The mold is opened, and the molded unprocessed intraocular hydrogel contact lens is separated from the mold.
[0334] The molded raw silicone hydrogel contact lenses are mechanically opened to each of the lens molds contained therein. The molded raw in-vitreous silicone hydrogel contact lenses are attached to a male half-mold or a female half-mold. If attached to a male half-mold, the molded raw in-vitreous silicone hydrogel contact lenses are separated using an ultrasonic device; if attached to a female half-mold, the molded raw in-vitreous silicone hydrogel contact lenses are manually separated from the lens-attached female half-mold.
[0335] The separated raw intravitreal silicone hydrogel contact lens can be extracted with a mixture of propylene glycol:water (50:50). Preferably, the separated raw intravitreal silicone hydrogel contact lens is subjected to subsequent extraction / hydration, coating, and autoclave processes as follows: the raw intravitreal silicone hydrogel contact lens is immersed in a bath containing deionized water or an aqueous solution of Tween 80 (500 PPM) for about 60 minutes, then immersed in a bath containing an aqueous solution of polyacrylic acid (PAA, molecular weight 450K) at a concentration of about 0.1 wt% at 40°C for about 120 minutes, then immersed in a bath containing a PBS solution at room temperature for about 60 minutes; A polypropylene lens packaging shell (or blister) containing 0.65 mL of in-package-coating packaging saline prepared according to the procedure described in Example 19 of U.S. Patent No. 8480227 is packaged / sealed (one lens per shell); finally, it is autoclaved at 121°C for about 45 minutes. A hydrogel coating is formed on the surface of each of the resulting in-in-the-ocular SiHy contact lenses.
[0336] Figure 1 shows images of an unprocessed ocular SiHy contact lens obtained before opening the mold. Figure 1a shows that a magnetized insert (produced from a composition for forming a magnetized insert containing 1 wt% magnetite) is centered by the magnet of the unprocessed ocular silicone hydrogel contact lens, and Figure 1b shows that a non-magnetized insert could not be centered by the magnet, as shown with an insert that is offset from the center.
[0337] The delamination of the intraocular SiHy contact lens obtained in this way was examined according to the procedure described in Example 1. Microscopic examination revealed that no bubbles were observed at the interfaces between the magnetized insert and the SiHy bulk material of the intraocular silicone hydrogel contact lens. In other words, no delamination occurred.
[0338] Example 3
[0339] The present embodiment illustrates that a magnetized insert A can be formed by printing a magnetic color image (e.g., an annular ring around the edge of the insert) on at least one of the front or back of a magnetite annular ring along the edge of the insert. This provides a magnetic material sufficient to control the position of the magnetized insert with an external magnet during mold casting of an intraocular SiHy contact lens.
[0340] Preparation of siloxane-containing binder polymers ("binder polymers")
[0341] The binder polymer is a silicone hydrogel copolymer and is prepared according to a two-step process described in Example 2 of U.S. Patent Application Publication No. 2017-0183520A1. In the first step, a reactive mixture of DMA (38.53 parts by weight), TRISMA (24.49 parts by weight), HEMA (10.10 parts by weight), Betacon (21.47 parts by weight), VAZO-52 (parts by weight), and 2-mercaptoethanol (1.38 parts by weight) is copolymerized using ethyl acetate (158 parts by weight) as the solvent. This copolymerization reaction is carried out in ethyl acetate under nitrogen at 50°C for about 24 hours. In this process, VAZO-52 is used to initiate the polymerization, and 2-mercaptoethanol is used as a chain transfer agent. 2-Mercaptoethanol chain transfer agents control molecular weight and prevent gelation during the polymerization process.
[0342] In the second step, isocyanatoethyl methacrylate (IEM) (3.43 parts by weight) and dibutyltin dilaurate (DBTDL) (0.08 parts by weight) are added to the previously produced copolymer to functionalize it with ethylene, thereby enabling chemical crosslinking. DBTDL acts as a catalyst in the reaction between the isocyanate groups of IEM and the hydroxyl groups of HEMA units within the copolymer produced in the first step. Once the reaction of IEM is complete, ethyl acetate is exchanged with PrOH, and the binder solution is concentrated to a solid content of 65% to 70% by weight.
[0343] Ink formulation
[0344] A magnetite (Fe3O4, Sensient Cosmetics, as described above, particle size 2 μm to 5 μm)-containing ink is prepared with the following composition: 10 wt% of black iron oxide (50%, dispersed in 1-propanol); 38 wt% of the binder solution prepared as described above; 1 wt% of Omnirad 754 (formerly Irgacure 754, 2-[2-(2-oxo-2-phenylacetyl)oxyethoxy]ethyl 2-oxo-2-phenylacetate); and 51 wt% of PrOH. It should be understood that any photoinitiator, preferably Omnirad 1173, more preferably Omnirad 2959, may be used.
[0345] The formulation obtained in this way is placed into an ink cup coupled to a stainless steel printing plate having a ring pattern with an outer diameter of 12.96 mm and an inner diameter of 4.95 mm.
[0346] Manufacturing of magnetized inserts
[0347] According to the procedure described in Example 2, an insert (with a diameter of about 6 mm to 7 mm) is mold-cast from the composition for forming a base insert (prepared in Example 2). Using a pad printing system similar to that described in Fig. 2 of U.S. Patent Application Publication No. 2020 / 0376787 A1, a magnetic annular ring is printed on the front of the insert along the edge of the insert using ink (prepared as described above, having magnetic particles inside). The amount of magnetic particles is increased by varying the number of prints on the insert from 1 to 20. The print(s) are cured with an H-bulb (Heraeus Noblelight) at a belt speed of 20 feet per minute using a UV Fusion lamp system to obtain magnetized inserts, each having a magnetic annular ring on top.
[0348] Manufacture of ocular implantable silicone hydrogel contact lenses
[0349] From the magnetized insert prepared as described above and the silicone hydrogel lens formulation prepared in Example 2, an ocular silicone hydrogel contact lens is prepared according to the procedure described in Example 2.
[0350] It was observed that a magnetized insert (with a magnetic annular ring printed on the top) could be positioned in the center of an implantable silicone hydrogel contact lens. The delamination of the implantable SiHy contact lens obtained in this way was examined according to the procedure described in Example 1. Microscopic examination revealed that no bubbles were observed at the interfaces between the magnetized insert and the SiHy bulk material of the implantable silicone hydrogel contact lens. In other words, no delamination occurred.
[0351] All publications, patent documents, and patent application publications cited prior to this invention are incorporated herein by reference in their entirety.
Claims
Claim 1 A method for manufacturing an embedded hydrogel contact lens, comprising: (1) a step of creating a magnetized insert having a diameter of 13.0 mm or less and having a front surface and a rear surface opposite thereto, wherein the insert is made of a polymer material and includes magnetic particles; (2) a step of manufacturing a lens mold comprising a female half-mold having a first molding surface and a male half-mold having a second molding surface, wherein the female half-mold and the male half-mold are configured to accommodate each other so that a cavity is formed between the first molding surface and the second molding surface when the mold is closed; (3) a step of placing a magnetized insert and introducing a lens-forming composition, regardless of the order, placing a magnetized insert in the lens mold and introducing a lens-forming composition into the lens mold, wherein the magnetized insert is immersed in the lens-forming composition within the lens mold and the magnetized insert is placed in the center of the lens mold and fixed in place using a magnet placed below the lens mold. (4) A step of curing a lens-forming composition in a lens mold while fixing a magnetized insert in the center of the lens mold using a magnet to form an unprocessed intraocular hydrogel contact lens, wherein a bulk hydrogel material produced from the lens-forming composition is included in the unprocessed intraocular hydrogel contact lens and a magnetized insert is embedded in the bulk hydrogel material and placed in the center of the unprocessed intraocular hydrogel contact lens; (5) A step of separating the lens mold produced in step (4) into a female half-mold and a male half-mold, wherein the unprocessed intraocular hydrogel contact lens is attached to a lens-attaching half-mold, which is either the female half-mold or the male half-mold; (6) A step of detaching the unprocessed intraocular hydrogel contact lens from the lens-attaching half-mold;and (7) a post-forming process including a hydration process on an unprocessed intraocular hydrogel contact lens, and one or more other processes selected from the group consisting of extraction, surface treatment, packaging, sterilization and combinations thereof, a method for manufacturing an intraocular hydrogel contact lens.; Claim 2 A method for manufacturing an ocular hydrogel contact lens, wherein, in claim 1, the curing step (4) of the lens-forming composition is performed by chemical irradiation using UV and / or visible light. Claim 3 A method for manufacturing an ocular-implantable hydrogel contact lens, wherein, in claim 1, the curing step (4) of the lens-forming composition is performed thermally by heating the first molding assembly in an oven at one or more curing temperatures selected from 40°C to 100°C. Claim 4 An intraocular hydrogel contact lens comprising an anterior surface, a posterior surface opposite thereto, a bulk hydrogel material, and a magnetized insert embedded in the bulk hydrogel material, wherein the magnetized insert is made of a polymer material and contains magnetic particles, the magnetized insert has a diameter of 13.0 mm or less and has an anterior surface and a posterior surface opposite thereto, the magnetized insert is located in the central part of the intraocular hydrogel contact lens, and the intraocular hydrogel contact lens is not easily delaminated, as evidenced by the absence of microscopically observable bubbles at the interface between the bulk material and the insert within the intraocular silicone hydrogel contact lens after autoclaving in a lens storage solution in a sealed package, and the lens storage solution is a buffered saline solution with a pH of 7.1 ± 0.
2. Claim 5 An ocular hydrogel contact lens according to claim 4, wherein the magnetizing implant comprises magnetic particles distributed in the polymer material of the magnetizing implant. Claim 6 An ocular hydrogel contact lens according to claim 4, wherein the magnetizing insert comprises a magnetic coating on either the front or rear surface, and said magnetic coating comprises magnetic particles. Claim 7 An ocular hydrogel contact lens according to claim 4, wherein the magnetizing insert comprises a magnetic color image printed on either the front or back surface using at least one ink containing magnetic particles, and said magnetic color image contains magnetic particles. Claim 8 An ocular-implantable hydrogel contact lens according to claim 7, wherein the magnetic color image comprises an annular ring. Claim 9 An ocular hydrogel contact lens according to any one of claims 4 to 8, wherein the polymer material of the magnetized insert comprises one or more repeating units of a polymerizable photochromic compound or a photochromic vinyl monomer, one or more repeating units of a UV-absorbing vinyl monomer, one or more repeating units of a UV / HEVL-absorbing vinyl monomer, one or more repeating units of a fluorescent vinyl monomer, or a combination thereof. Claim 10 An intraocular hydrogel contact lens according to any one of claims 4 to 8, wherein the magnetizing implant comprises one or more color filtering materials for color blindness correction, diffractive materials, high refractive index materials, or combinations thereof. Claim 11 An ocular hydrogel contact lens, wherein, in any one of paragraphs 4 to 8, the polymer material of the magnetized insert is a hard plastic material. Claim 12 An ocular hydrogel contact lens, wherein, in any one of claims 4 to 8, the polymer material of the magnetized insert is a cross-linked silicone polymer having a three-dimensional (3D) polymer network structure, being water-insoluble, and having an equilibrium water content of 5 weight% or less. Claim 13 An ocular hydrogel contact lens, wherein, in any one of paragraphs 4 to 8, the polymer material of the magnetized insert is a rigid gas-permeable material. Claim 14 An ocular hydrogel contact lens according to any one of claims 4 to 8, wherein the polymer material of the magnetized insert is a hydrophobic crosslinked acrylic material having an equilibrium water content of less than 5 weight%, containing 55 mol% or more of repeating units of one or more acrylic monomers and / or one or more repeating units of acrylic crosslinking agents, and containing 6 mol% or more of repeating units of one or more vinyl crosslinking agents. Claim 15 In paragraph 14, an intraocular hydrogel contact lens in which the hydrophobic insert is rigid. Claim 16 An ocular hydrogel contact lens, wherein, in any one of claims 4 to 8, the bulk hydrogel material is a non-silicone hydrogel material comprising 50 mol% or more of a repeating unit of one or more hydroxyl-containing vinyl monomers. Claim 17 An intraocular hydrogel contact lens according to claim 16, wherein one or more hydroxyl-containing vinyl monomers are selected from the group consisting of hydroxyethyl (meth)acrylate, glycerol (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 3-amino-2-hydroxypropyl (meth)acrylate, N-2-hydroxyethyl (meth)acrylamide, N-3-hydroxypropyl (meth)acrylamide, N-2-hydroxypropyl (meth)acrylamide, N-2,3-dihydroxypropyl (meth)acrylamide, N-tris(hydroxymethyl)methyl (meth)acrylamide, vinyl alcohol, allyl alcohol, and combinations thereof. Claim 18 An ocular-implantable hydrogel contact lens, wherein, in any one of paragraphs 4 to 8, the bulk hydrogel material is a silicone hydrogel material. Claim 19 An ocular hydrogel contact lens, wherein the bulk hydrogel material comprises (a) repeating units of one or more first polysiloxane vinyl-based crosslinking agents having one organic radical containing one or more H-bond donors and one methyl substituent in each unit, and (b) repeating units of one or more hydrophilic vinyl monomers, wherein the content of the one or more H-bond donors is 0.8 meq / g or more based on the molecular weight of the one or more first polysiloxane vinyl-based crosslinking agents.
Citation Information
Patent Citations
Contact lens
JP2009098457A
Method of moulding of silicon containing contact lenses
KR1019930703141A
Facilitating release of silicone hydrogel ophthalmic lenses
KR1020070080847A
Methods and systems for leaching and releasing silicone hydrogel ophthalmic lenses with alcohol solutions
KR1020090007682A
Method of Making Hydrogel Contact Lenses
KR1020090115165A
